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ABSTRACT 
 For over a decade, DNA microarrays have dominated genome-wide gene expression 
studies, revealing widespread effects of drug exposure on neuronal gene expression. More 
targeted single gene approaches have added invaluable insights into their behavioral, 
biochemical, and molecular effects. The more powerful next-generation sequencing 
technology may soon supplant microarrays for the analysis of complex transcriptomes. RNA-
Seq is unparalleled in its ability to identify and quantify low-abundance transcripts without 
prior sequence knowledge, facilitating detection and investigation of known and novel 
alternative splicing events, imprinting, and RNA editing, among others. We first used RNA-Seq 
technology to catalog microRNA (miRNA) expression in total tissue and at postsynaptic 
densities (PSDs) from control and cocaine-treated mice. Neurons modulate gene expression 
with subcellular precision through excitation-coupled local protein synthesis, a process that 
may be regulated in part through the involvement of miRNAs. We identified cocaine-
responsive miRNAs, synaptically-enriched and depleted miRNA families, and confirmed 
cocaine-induced changes in protein expression for several predicted target genes. The miR-8 
family was found to be highly enriched and cocaine-regulated at the PSD, where its members 
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may modulate expression of cell adhesion molecules. We then used next-generation 
sequencing of mRNAs purified from the same brain regions to gain a more complete picture of 
the molecular response to chronic cocaine exposure and withdrawal. Bioinformatic analysis 
revealed paradigm-specific regulation of multiple components of a limited number of 
signaling pathways. We identified signaling pathways that utilize distinctly different sets of 
receptors and signaling molecules under control conditions, after chronic exposure to cocaine, 
and during withdrawal. The Rho-GEFs expressed in the nucleus accumbens and localized to 
the postsynaptic density were reviewed because they are strategically positioned to effect 
rapid alterations in dendritic spine structure. Structural changes mediated by synaptic Rho 
guanine nucleotide exchange factors (GEFs) control actin cytoskeletal rearrangements and 
contribute to the long-lasting effects of cocaine. This review is then followed by a brief look at 
several ongoing and completed collaborative bioinformatics projects. Future studies will 
employ integrative approaches that combine mRNA, miRNA, and protein expression profiling 
with focused single gene studies and innovative behavioral paradigms and will facilitate 
development of integrated approaches to treat addiction. 
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CHAPTER 1  
Global approaches in the analysis of drug-induced gene 
expression 
 
 
System-wide analysis of gene expression 
Microarray versus RNA-Seq: The advantages of sequencing 
 DNA microarrays have dominated genome-wide studies of gene expression for more 
than a decade. However, the use of next-generation sequencing methods for the analysis of 
complex transcriptomes may soon supersede the use of microarrays1. Microarrays have been 
instrumental in the interrogation and profiling of DNA-protein interactions, identification of 
single-nucleotide polymorphisms, and comparative analyses of mRNA expression2. Any 
approach that attempts to deliver a global snapshot of gene expression has limitations, 
however microarrays are limited in a number of ways that next-generation sequencing is not. 
For example, microarrays rely on base complementarity between the probe and the mRNA 
and therefore researchers must consider artifacts of cross-hybridization when dealing with 
highly homologous genes or isoforms3. Microarrays contain a pre-defined set of 
oligonucleotide probes designed using existing gene annotations for organisms with known 
genome sequences1, whereas sequencing facilitates the identification and absolute 
quantification of low-abundance transcripts without prior knowledge of the sequence3-6. The 
sequencing approach, unlike microarray, has low background signal because of the 
unambiguous nature of sequence mapping and has increased sensitivity for low-abundance 
transcripts1,6. Additionally, sequencing enables the detection and investigation of alternative 
splicing (both known and novel)4,5,7, imprinting and allele specific expression8, sequence 
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variation6, and RNA editing9. And finally, microarrays provide far less data than current next-
generation sequencing technologies, which can produce gigabases (109 nucleotides) of 
sequence from a single experiment, enabling detection of very minor transcripts1. 
Explosion of the sequencing field 
 In 1975, Sanger and Coulson published their breakthrough paper on rapid 
determination of sequences in bacteriophage φX174 DNA using synthetic oligonucleotide 
primers and Escherichia coli DNA polymerase I10. This was followed in 1977 by two landmark 
Sanger et al. publications detailing the use of radioactively labeled, chain-terminating 2’,3’-
dideoxynucleotide phosphates (ddNTPs) for rapid DNA sequencing with DNA polymerase11, 
revolutionizing modern molecular biology and characterizing the full genome of φX17412. Also 
in 1977, Maxam and Gilbert presented an innovative method of sequencing by partial 
cleavage of terminally labeled DNA molecules at each of the four bases followed by gel 
electrophoresis13. 
 Since its introduction in the mid-1970s, rapid sequencing research has exploded, as 
evidenced by the exponential increase in publications in the past few years (Fig. 1.1). The first 
truly high-throughput sequencing device was introduced by Lynx Therapeutics in the 1990s. 
Massively parallel signature sequencing (MPSS) employed microbead arrays for the analysis of 
mRNA transcript levels. This approach involved in vitro cloning of cDNA templates on a 
monolayer of slide-fixed microscopic beads followed by ligation of tagged adaptor sequences, 
and produced ‘signature’ sequences ranging from 16 to 20 nucleotides in length14,15. 
 In 2005, two new methods of next-generation sequencing were introduced: (1) 
pyrosequencing, or ‘sequencing-by-synthesis’, which detects pyrophosphate release on 
nucleotide incorporation, was developed by 454 Life Sciences16, and (2) multiplex 
‘sequencing-by-ligation’ of mate-paired polymerase colonies (‘polonies’)17. Also in 2005, Lynx  
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Figure 1.1  PubMed references for high-throughput sequencing by year. 
The number of publications in Entrez PubMed (http://www.ncbi.nlm.nih.gov/pubmed) by indicated 
year for the search term ‘“RNA-seq” or “next-generation sequencing” or “massively parallel sequencing” 
or “high-throughput sequencing” or “deep sequencing”’. Hashed bar depicts the 2011 predicted total. 
Symbols: ‡, publication total obtained May 11, 2011; §, projected total for December 31, 2011. 
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Therapeutics merged with another sequencing company, Solexa. In 2006, Solexa introduced 
the Genome Analyzer, which, using sequencing by synthesis with fluorescent reversible 
terminator technology, provided up to 1 gigabase (Gb) of sequence in a single sequencing 
run. In 2007, Illumina aquired Solexa, and as of 2011, Illumina sequencers generate up to 600 
Gb of sequence per run18. An additional technology, SOLiD (Sequencing by Oligonucleotide 
Ligation and Detection) from Applied Biosystems, gained renown in 2008 with the sequencing 
of the stem cell transcriptome4. Next-next-generation (3rd generation) sequencing, in which 
single molecules are sequenced without prior amplification, are considered the future of the 
sequencing field19. 
Limitations in current RNA-Seq methods 
 High-throughput sequencing is an extremely powerful tool for biological analysis, but 
it would be shortsighted not to touch on some of its limitations. The density of sequence reads 
varies along the length of a transcript, indicating the existence of sequence bias at some point 
during the library preparation or sequencing process (Fig. 1.2)20,21. There are data showing an 
underrepresentation of AT-rich and GC-rich regions in Illumina RNA-Seq data, which is likely 
attributable to sequence bias during the reverse transcription and amplification steps of 
library preparation3,22,23. Strand-specific sequencing, in which the sequencing adapters are 
ligated to the RNA fragment prior to amplification, may show a more even distribution of 
aligning reads along the length of the gene; this method, however, requires additional 
manipulation of highly labile RNA prior to its conversion to more stable cDNA19. Other 
difficulties of traditional RNA-Seq include issues of quantifying very low abundance 
transcripts, problems with profiling repetitive regions of the genome, and trouble in 
quantifying small RNAs and RNA with a short half-life19. Next-next-generation sequencing 
provides an alternative that avoids many of the weaknesses of currently used methods.  
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Figure 1.2  Exon coverage profile with RNA-Seq using different sequencing platforms. 
Expression profile of poly(A)+ mRNAs from NAc tissue lysates and striatal PSDs. Data from NAc samples 
were obtained from 37-cycles of sequencing on the Genome Analyzer IIx. Data from PSD samples were 
generated using the HiSeq 2000 platform and sequencing was carried out for 100-cycles. Numbers to 
the left of each track indicate maximal read number for that sample. 
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 Challenges accompany the rapidly improving technology and accumulation of 
datasets containing vast amounts of information, however. Many biologists struggle to make 
scientific sense of the data at hand, while many computer scientists are not equipped with the 
biology training to tackle the relevant questions on their own. A growing number of tools are 
available to assist in the analysis of high-throughput datasets, including packages for 
sequence alignment24, de novo genome and transcriptome assembly25, analysis of alternative 
splicing26, functional category assessment, and identification of signaling pathway 
enrichment27-30. The field is in its infancy, and, at present, few ‘user friendly’ and fully 
customizable packages exist for the comprehensive analysis of sequencing data. It will be 
exciting to follow new and improving developments as they become available. 
Applying high-throughput techniques to the analysis of gene expression in 
the brain 
mRNA studies 
 In one of the first global analyses of mRNA expression in the mammalian brain, 
Eberwine et al. amplified transcripts from single dissociated rat hippocampal neurons31. 
Through this analysis they found differing expression profiles in morphologically 
indistinguishable neurons, highlighting the extraordinary complexity that dictates neuronal 
gene regulation31. 
 In 2003, Ule and colleagues presented a novel method to analyze direct interactions 
between the RNA binding protein and splicing cofactor, Nova, and its target mRNAs32. The 
technique, cross-linking and immunoprecipitation (CLIP), involves direct ultraviolet irradiation 
of brain tissue, causing the formation of covalent bonds between directly juxtaposed proteins 
and RNAs. They then used coimmunoprecipitation (co-IP) of Nova, followed by partial RNA 
digestion and proteinase K digestion to obtain RNA sequences of 60-100 nt. They sequenced 
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340 Nova CLIP tags, identifying many novel Nova alternative splicing targets32. 
 Expanding on the role of Nova proteins in the control of neuronal alternative splicing, 
Ule et al. used a specially-designed Affymetrix splicing array to assess alternative splicing in 
the brains of two knockout mice, Nova1-/- and Nova 2-/-, identifying nearly 50 differentially 
spliced alternative exons33. Shortly thereafter, Ule et al. used bioinformatic techniques to 
characterize an RNA map of Nova-dependent alternative splicing in the brain, identifying 
splicing enhancer and silencer motifs in and around alternatively spliced exons34. 
 With the advent of next-generation sequencing techniques, the same group 
developed HITS-CLIP, high-throughput sequencing of RNA isolated by crosslinking 
immunoprecipitation35. This technique used the previously described32 CLIP method paired 
with RNA-Seq of isolated mRNAs. They performed a genome-wide characterization of Nova-
RNA interactions, identifying an added role for Nova in the regulation of polyadenylation in 
the mammalian brain35. These examples, and others not included, underscore the utility and 
power of genome-wide approaches in the study of gene expression in the mammalian brain. 
microRNA studies 
 microRNAs (miRNAs) are a class of endogenous 21-25 nucleotide small RNAs that 
modulate gene expression through binding complementary sequences in the 3’-untranslated 
regions (3’-UTRs) of target mRNAs36. Hundreds of miRNAs are expressed in the mature 
mammalian brain37-40, where they are involved in the control of synapse development and 
neuronal plasticity41. In the biogenesis of mature miRNAs, long primary miRNA (pri-miRNA) 
transcripts are successively cleaved into shorter preliminary miRNA (pre-miRNA) hairpins, 
exported from the nucleus, and cleaved to make ~22 nt duplex RNAs prior to loading into 
RNA-induced silencing complexes (RISCs)36. Each fully assembled RISC contains an Argonaute 
protein (AGO1-4 in human and mouse), and a single mature miRNA42. The RISC interacts with 
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target mRNAs via complementary base pairing interactions specified by the miRNA sequence, 
and either represses translation or induces mRNA degradation. AGO2 is the only catalytically 
active AGO family member in humans and mice; it has endonuclease (‘slicer’) activity and the 
ability to cleave target mRNAs36. 
 Neurons can modulate gene expression with subcellular precision; polyribosomes and 
mRNAs are found at the base of dendritic spines and are involved in localized protein 
synthesis43,44. Two recent publications present evidence that individual synapses may act 
independently in the local control of excitation-coupled protein translation41,45. A subset of 
miRNAs copurify with polyribosomes isolated from E18 rat cortices, suggesting a role for 
miRNAs in fine-tuning localized translation of mRNAs in dendrites46. Localization of the miRNA 
processing enzyme DICER and the critical RISC component AGO2 in mouse cortical and 
hippocampal slices by electron microscopy lent credence to this hypothesis47. Further studies 
identified the RISC component and RNA helicase Armitage (also known as MOV10) at the 
synapse and established a role for RNA-induced silencing in the control of synaptic gene 
expression, learning, and memory48,49. The demonstration that miR-134 was a synapto-
dendritically localized miRNA with a role in activity-dependent regulation of hippocampal 
dendritic spine size through its effects on the kinase LIMK150 was followed by studies 
demonstrating roles for miR-132 and miR-138 in dendritic remodeling and synaptogenesis51,52. 
 Applying the HITS-CLIP technique35 of protein crosslinking and high-throughput 
sequencing, Chi et al. simultaneously generated two distinct RNA-Seq databases by 
immunoprecipitating AGO2 from mouse brain53. One database provided a genome-wide map 
of AGO2-mRNA binding sites, and the other detailed the association of AGO2 with specific 
miRNAs. Through bioinformatic means, they were able to characterize a combined global 
AGO2-miRNA-mRNA map, providing further evidence for the importance of miRNA-mediated 
control of gene expression in the brain53. 
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 miRNAs are implicated in the pathophysiology of a variety of neuropsychiatric 
disorders and mental retardation syndromes, including Alzheimer’s disease, Parkinson’s 
disease54, Huntington’s disease55, schizophrenia56,57, bipolar disorder58, Fragile X mental 
retardation59, and Rett syndrome60,61. Studies suggest that miRNAs play an important role in 
the local control of dendritic morphology through fine-tuning translation of synaptically-
localized mRNAs41. miRNAs likely participate in long-lasting forms of synaptic plasticity 
through the modulation of regulatory pathways that involve controlled dendritic mRNA 
trafficking, excitation-coupled modulation of synaptic mRNA translation, alterations to the 
actin cytoskeleton, neurotransmitter metabolism and peptide hormone processing62. 
Proteomic studies 
 Characterization of the complete complement of proteins expressed in the brain has 
been ongoing for years. Current proteomic approaches lack the same level of sensitivity seen 
in current high-throughput sequencing techniques, limited by our inability to amplify proteins 
as we amplify nucleic acids63. 
 Expression neuroproteomic studies focus on quantitative and qualitative profiling of 
the neural proteome using gel electrophoresis, 2-dimensional difference in gel electrophoresis 
(2D-DIGE), and liquid chromatography-tandem mass spectrometry (LC-MS/MS)64. Functional 
neuroproteomic studies tackle the characterization of regulatory networks, signaling 
pathways, subcellular localization, and complex formation64. The Human Brain Proteome 
Project is an organization that oversees large-scale integration of brain proteome studies65. 
 Over 1,000 proteins have been identified in the mammalian postsynaptic proteome66. 
The postsynaptic proteins are organized into signaling complexes and networks, including the 
NMDA receptor complex67, dozens of actin cytoskeletal and scaffolding proteins68, and 
approximately 60 kinases64. 
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 One aspect of proteomics addresses post-translational modifications to proteins, 
including phosphorylation, glycosylation, nitrosylation, carbonylation, palmitoylation, etc. 
Phosphoproteomic studies have identified more than 1,500 phosphorylation sites in isolated 
postsynaptic densities (PSDs) from different brain regions64. Studies have revealed widespread 
activity-dependent phosphorylation of specific target proteins in the PSD in response to 
neurotransmitter stimulation69. For example, a recent study of the postsynaptically-localized 
Rho GDP/ GTP exchange factor (GEF) Kalirin-7 found 39 different phosphorylation sites using 
LC-MS/MS70. 
Cocaine abuse 
History of cocaine 
 In 1977, the National Institute on Drug Abuse (NIDA) released its first report on 
recreational cocaine use in the United States71. The report detailed the present state of 
cocaine-related research, including the history of cocaine use and abuse, the chemical 
structure and metabolism of the drug, behavioral studies, and a survey of the human impact 
of cocaine use. The coca plant, Erythroxylon coca, is indigenous to Western South America, 
where for millennia people have chewed the coca leaf for its stimulant and perceived 
medicinal qualities. Cocaine extract was first purified in 1880, and by the turn of the 20th 
Century it was widely used in a variety of commercially available products, such as soft drinks, 
wines, and many over-the-counter medicines. The Harrison Narcotics Act of 1914 ushered in a 
new era of Federal oversight, restricting the availability of cocaine and coca extracts, and 
imposing significant fines for non-medical use71. 
 By the late 1960s, researchers had developed many of the animal models of substance 
abuse still in use today, including the paradigm of self-administration. The molecular and 
biochemical underpinnings of substance abuse and addiction were nearly entirely unknown, 
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and the impact on the general population of the United States was quite minor, accounting 
for just 111 documented deaths from 1971 to 197671. In the subsequent 35 years, our 
knowledge of cocaine and its biological activity has increased immensely, as has the burden 
on the general population of cocaine-related morbidity and mortality. 
Societal impact of substance abuse and addiction 
 Repeated cocaine use may lead to addiction and a number of other serious and 
adverse health consequences, and cocaine accounts for nearly one third of all drug-related 
emergency room visits72. In 2007, there were 1.6 million cocaine users in the United States who 
met the Diagnostic and Statistical Manual of Mental Disorders criteria for dependence or 
abuse of cocaine in the past year73,74. Approximately 90% of addicted individuals eventually 
resume drug taking, many after prolonged periods of abstinence75. Our understanding of the 
molecular underpinnings of cocaine abuse and addiction is far from complete, and there are 
currently no FDA-approved medications to treat cocaine addiction76. Studies such as those 
detailed herein aim to elucidate the genetic changes underlying the response of the brain to 
cocaine and may ultimately help identify new targets for treating cocaine addiction. 
 Drug abuse research primarily aims to uncover the molecular and cell biological 
mechanisms causing addiction in humans. Addiction is currently a clinical diagnosis, defined 
as the compulsive need for and use of a habit-forming substance despite its harmful 
consequences73. Until recently, evidence in support of an appropriate animal model of 
addiction was limited. In 2004, Piazza and colleagues put forth convincing evidence in support 
of addiction-like behavior in the rat77. The authors described rats trained to self-administer 
cocaine that, when cocaine was paired with an aversive foot shock, persisted seeking drug77; 
this behavior is present in a minority of rats and human drug addicts and is a strong predictor 
of relapse potential after withdrawal. The endogenous reward system of the brain, on which 
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drugs of abuse act, is similar in many different species. For decades, the use of a variety of 
animal models, to study the behavioral and neurochemical response to drug exposure, has 
shed light on the neuroadaptations occurring inside the brains of human drug abusers. 
The reward circuitry of the brain 
 Drugs of abuse induce persistent biochemical and morphological changes in a 
number of regions throughout the brain via distinct acute mechanisms of action. Abundant 
evidence, from both animals and humans, identifies the limbic system as the convergence 
point for all drugs of abuse78-83. The limbic regions of the brain control emotions, motivations, 
and behavior. The mesocorticolimbic dopamine pathway, which involves a subset of all limbic 
structures, is activated by normal physiologic rewards such as food, drink, social interaction, 
and sex84-86. The mesocorticolimbic system includes dopaminergic projections from the ventral 
tegmental area (VTA) to the nucleus accumbens (NAc) and prefrontal cortex (PFC) as well as 
glutamatergic projections from the PFC to the NAc (Fig. 1.3)87. Although drugs of abuse 
originate from a diverse array of chemical classes and have a variety of different primary 
targets, their effects all ultimately converge on the mesocorticolimbic dopamine neurons of 
the VTA88. Other neurotransmitters, including γ-aminobutyric acid (GABA), opioid peptides, 
serotonin, acetylcholine, and endogenous cannabinoids, are also involved in the signaling of 
addiction89-91. The convergence of these myriad signaling systems has led many to 
hypothesize that the NAc is the key integration point in the rewarding effects seen with drugs 
of abuse83,92-95. 
 The neuronal circuitry of drug craving is complex and incompletely understood; 
however, data from animal studies and functional imaging of the brains of human addicts 
have uncovered a number of important details (Fig. 1.3). A variety of drug-related cues may 
spur a reformed addict to resume drug-seeking behavior; these cues include stress, exposure 
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Figure 1.3 The reward circuitry of the mesocorticolimbic dopamine system. 
The VTA is comprised of both GABAergic and dopaminergic neurons that project to the NAc, dorsal 
striatum, and PFC. The neurons of the NAc receive glutamatergic input from the PFC, amygdala, and 
hippocampus and send GABAergic eerents to the VP, back to the VTA, and to motor regions. 
Glutamatergc aerents carry motivational signals to the NAc. The NAc signals function to direct the 
execution of goal-oriented behavior, including sending signals to motor control regions (not shown). 
The mixed cholinergic, glutamateric, and GABAergic eerents from the LTD and PPT modulate signaling 
in the VTA. Coloring of structures reects neurotransmitter type, with multi-colored structures (eg. VTA) 
using more than one neurotransmitter to signal. 
 
Abbreviations: LDT/PPT, laterodorsal tegmental nucleus/pedunculopontine tegmental nucleus; NAc, 
nucleus accumbens; PFC, prefrontal cortex; VP, ventral pallidum; VTA, ventral tegmental area. 
 
* Figure adapted from Kauer and Malenka, Nat. Rev. Neurosci., (2007)87 and Wolf, M.E. in Basic 
Neurochemistry: Molecular, Cellular, and Medical Aspects, (2006)88. 
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to a small dose of drug, and/or exposure to drug paraphernalia or the drug-related 
environment88,90. These cues activate glutamatergic neurons from the PFC that synapse on the 
medium spiny neurons of the NAc (shown in blue in Fig. 1.3). Aspects of the normal stress 
response in the brain, mediated by the circuitry of the hypothalamic-pituitary-axis, exhibit 
profoundly disrupted regulation in the brains of chronic drug users88. The PFC controls the 
cognitive and executive function aspects of drug-taking behavior while the other brain 
regions involved in the mesocorticolimbic circuitry are thought to control various components 
of learning, memory, and motivational significance that modulate drug-seeking behavior90. It 
is likely a combination of cognitive dysfunction with increased motivation to take a drug, 
enhanced conditioned emotional responses, and decreased inhibitory control/judgment that 
dictate compulsive drug-seeking behavior88. 
 Chronic cocaine exposure elicits morphological changes in multiple areas of the 
mesolimbic dopaminergic pathway, including the NAc88. For example, increased dendritic 
spine size and density are observed in the MSNs of mice following both experimenter-
administered68,96-98 and self-administered cocaine99. The biology underlying the behavioral and 
motivational responses experienced by drug abusers are generally described by two 
phenomena: sensitization and synaptic plasticity. Sensitization is the progressive and 
persistent amplification of behavioral and motivational responses to a fixed dose of drug93,95. It 
persists for weeks, months, and years after cessation of drug taking and is thought to play an 
important role in the risk of a reformed addict for relapse to drug taking behavior100-102. 
Synaptic plasticity is the phenomenon whereby the strength of the connection between two 
neurons changes strength. This change could be due to alterations in presynaptic 
neurotransmitter release, postsynaptic ion channel composition or conductivity, the 
morphology of the synapse, and/or second messenger signaling, all of which may be 
controlled by changes in gene transcription86. Synaptic plasticity is strongly implicated in all 
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types of learning, and current research suggests that drugs of abuse hijack normal synaptic 
plasticity mechanisms in the mesolimbic system with higher potency than natural rewards, 
leading to the development of sensitization84; addicts effectively “learn” to like the drug. 
Overview of signaling pathways 
 Medium spiny neurons (MSNs) are the inhibitory GABAergic neurons that comprise 90-
95% of the neurons in the nucleus accumbens87. Dendritic spines of medium spiny neurons 
receive dopaminergic inputs on their spine necks and glutamatergic inputs on their spine 
heads, positioning them well to integrate the complex signaling of the mesolimbic 
system95,103. When cocaine is present at the synapse, it blocks presynaptic dopamine re-uptake 
by the dopamine transporter (DAT), enhancing postsynaptic dopamine signaling by 
prolonging the time dopamine is present in the synapse and can bind postsynaptically. 
Dopamine signaling is central to the mechanism by which rewarding stimuli, both natural and 
synthetic, modulate behaviors and promote learning of rewarding behaviors88. Drugs of abuse 
activate dopamine neurons of the VTA through direct or indirect mechanisms, eliciting 
increased dopamine release and causing widespread changes – in gene expression, 
neurotransmitter release, signal transduction, neuronal excitability, and morphology – in 
dopamine-targeted neurons83,88. 
 A variety of drugs of abuse induce a sensitized state, akin to the increased synaptic 
efficacy of long-term potentiation (LTP), in the dopamine neurons of the VTA; dopamine 
transmission in response to the drug or drug-related cues is greatly increased over the drug-
naïve baseline 83. Increased responsiveness of ionotropic glutamate receptors of the α-amino-
3-hydroxy- 5-methyl-4-isoxazole propionic acid (AMPA) subtype govern this sensitization and 
may reflect altered AMPA receptor trafficking or subunit composition87. Furthermore, altered 
glutamatergic signaling has been implicated in behavioral responses to drugs of abuse83. 
16 
 
 Decreased GABA transmission in the VTA, mediated by exposure to opiates, ethanol, 
and cannabinoids, disinhibits efferent dopamine neurons, increasing dopamine release and 
signaling in the NAc, PFC, and other target areas (Figs. 1.3)88. Additionally, opiate drugs 
activate signaling in the NAc independent of their effects on VTA dopamine transmission 
through the binding of opiate peptides to presynaptic κ-opioid receptors and postsynaptic µ-
opioid receptors in the NAc88,90.  
 Chronic exposure to cocaine markedly increases expression of µ- and κ-opioid 
receptors in the NAc. Activation of µ-type receptors on dopamine neurons of the VTA 
stimulates synaptic dopamine release while presynaptic κ-type activation in the NAc is 
homeostatic, diminishing dopamine release104,105. In the NAc, µ-opioid receptor expression is 
primarily postsynaptic and κ-opioid receptors are both pre- and postsynaptic, although the 
postsynaptic subset predominates106. Cocaine exposure induces striatal expression of the 
opiate peptide dynorphin (and its precursors), which primarily binds the κ-opioid receptor, 
and treatment with κ-opioid agonists significantly reduces the behavioral effects of cocaine107. 
 Drugs of abuse directly and indirectly activate of Gαs and Gαi/o G-protein coupled 
receptors (GPCRs). Gαs GPCRs, such as the D1-like dopamine receptors, produce the second 
messenger cyclic adenosine monophosphate (cAMP) through activation of adenylyl cyclase. 
The resultant increase in intracellular cAMP levels increases the activity of the Protein Kinase A 
(PKA) family of Ser/Thr kinases. Activated PKA translocates to the nucleus where it 
phosphorylates the transcription factor CREB (cAMP response element binding), inducing 
transcription of a variety of target genes. Alternatively, Gαi/o GPCRs, such as the D2-like 
dopamine receptors, inhibit adenylyl cyclase, decreasing the amount of cAMP and decreasing 
downstream PKA signaling events108. Both D1 and D2 receptors act through additional 
signaling mechanisms to exert their full effects88. 
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 Importantly, dopamine signaling in mesolimbic MSNs performs a neuromodulatory 
role. The D1 receptor-PKA pathway influences neuronal excitability through PKA-mediated 
phosphorylation of voltage- and ligand-gated ion channels. Examples of regulated channels 
include glutamate receptors of both the AMPA and NMDA type, Na+ channels, and Ca2+ 
channels88. Increased intracellular Ca2+ levels mainly activate calcium/calmodulin-dependent 
protein kinases (CaM-kinases), ultimately turning on CREB and affecting gene expression108. 
Repeated stimulation produces persistent changes in gene expression that cause changes in 
pre- and postsynaptic neuronal morphology and alter the underlying neuronal circuitry88. 
Drugs of abuse exert their influence on the reward and motivation pathways in the brain by 
hijacking the normal signaling of activity-dependent plasticity and LTP. 
Global analyses of cocaine-mediated gene expression 
mRNA expression in postmortem human overdose victims and rodent models of 
addiction 
 The number of studies examining the effects of cocaine on one or a small number of 
genes dwarf the number of genome-wide expression studies. A number of comprehensive 
analyses, primarily using microarray, of cocaine-induced gene expression have been published 
over the years, in both animal models and human postmortem brain. These studies highlight 
the importance of components of the extracellular matrix, including cadherins, integrins, and 
matrix metalloproteinases109-112. In addition to the extracellular changes that occur in synapse 
formation, a significant body of work has focused on the role of actin cytoskeletal 
rearrangements, mediated in large part by the Rho-family of proteins, in the neural plasticity 
of drug abuse68,98,109,113-116. A variety of signaling molecules and receptors have also been 
implicated in the molecular responses of the brain to cocaine. Examples include the synaptic 
vesicle associated proteins α-synuclein and synaptotagmin, clathrin, several dopamine 
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receptors and the dopamine transporter, a number of ionotropic and metabotropic glutamate 
receptors, opiate receptors and opiate peptides, other neuropeptides, second messenger 
molecules such as the mitogen-activated protein kinases (MAPKs), calmodulin proteins, 
Ca2+/calmodulin-dependent protein kinases, other kinases, phosphatases, and a number of 
different transcription factors30,117-122. Despite decades of dedicated work, a complete picture of 
the gene expression changes that accompany cocaine exposure and withdrawal remains 
elusive. 
microRNAs and their emerging role in cocaine research 
 Several recent studies have investigated the role of AGO2 and miRNAs in biochemical 
and behavioral responses to cocaine exposure123-127. For example, qPCR and in situ analysis of 
specific bioinformatically-determined miRNAs identified let-7d, miR-124, and miR-181a as 
cocaine-regulated in rats123,127. Two studies by the Kenny group identified induction of miR-132 
and miR-212 in dorsal striatum after 7 days of cocaine self-administration in rats and implicate 
miR-212 in the behavioral and motivational response to cocaine through CREB, MeCP2, and 
brain derived neurotrophic factor (BDNF) signaling124,125. In addition, Schaefer et al. identified 
an overlapping subset of cocaine-induced and AGO2-knockdown-depleted miRNAs in D2 
dopamine receptor expressing neurons of the NAc, showing reduced cocaine self-
administration when AGO2 is depleted from D2 receptor expressing neurons126. 
 Together, these studies provide evidence that miRNA-mediated gene regulation plays 
an important role in the cocaine response. However, all of these studies were targeted to a 
small number of candidate miRNAs or used microarrays, which suffer from issues that plague 
microarray studies; these include cross-hybridization, high background signal, low dynamic 
range, and the inability to identify unknown miRNAs3, and thus these studies may not provide 
a complete picture of cocaine-induced changes in miRNA levels. 
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Proteomics and drug abuse research 
 Very few proteomic studies have looked at quantitative changes in postsynaptic 
proteins following exposure to drugs of abuse128. In one of the only drug-respone proteomic 
studies to date, Devi and colleages examined changes in the hippocampal postsynaptic 
proteome of mice after morphine injection, identifying just over 100 differentially regulated 
proteins129. They uncovered changes to a variety of proteins involved in mRNA and protein 
trafficking, intracellular signaling, rearrangement of the actin cytoskeleton, and other aspects 
of synaptic plasticity. They found significant upregulation of clathrin in the postsynaptic 
compartment after morphine, suggesting a role for the endocytic pathway in the response to 
drugs of abuse129. 
 Another recent study in rhesus monkeys used a combined proteomic approach to 
identify cocaine-regulated changes in cytosolic proteins from the NAc130. They uncovered 
cocaine-altered expression of proteins with known roles in the control of cell morphology, 
signal transduction, and synaptic plasticity, as well as components of the AMPA and NMDA 
receptor signaling complexes. They also looked for differentially regulated phosphorylation 
after cocaine, finding 15 proteins with increased phosphorylation following cocaine, including 
structural, signaling, and metabolic proteins130. 
The future of drug abuse research 
 Knockout and transgenic mouse models have been invaluable for investigations into 
the behavioral, biochemical, and molecular effects mediated by single genes. It is becoming 
increasingly clear, however, that the changes that occur as a result of drug abuse are 
incredibly widespread, affecting multiple brain regions and cell-types in a system-wide 
manner. These global studies emphasize the broad effects of drug exposure on neuronal gene 
expression, underscoring the need for an integrative approach that combines mRNA, miRNA, 
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and protein expression profiling in combination with focused single gene studies and 
innovative behavioral paradigms in the quest to uncover what drives addiction and develop 
integrated therapeutic approaches. 
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Abstract 
 MicroRNAs (miRNAs) are small RNAs that modulate gene expression by binding target 
mRNAs. The hundreds of miRNAs expressed in the brain are critical for synaptic development 
and plasticity. Drugs of abuse cause lasting changes in the limbic regions of the brain that 
process reward, and addiction is viewed as a form of aberrant neuroplasticity. Using next-
generation sequencing, we cataloged miRNA expression in the nucleus accumbens and at 
striatal synapses in control and chronically cocaine-treated mice. We identified cocaine-
responsive miRNAs, synaptically-enriched and depleted miRNA families, and confirmed 
cocaine-induced changes in protein expression for several predicted synaptic target genes. 
The miR-8 family, known for its roles in cancer, is highly enriched and cocaine-regulated at 
striatal synapses, where its members may affect expression of cell adhesion molecules. 
Synaptically-enriched cocaine-regulated miRNAs may contribute to long-lasting drug-induced 
plasticity through fine-tuning regulatory pathways that modulate the actin cytoskeleton, 
neurotransmitter metabolism, and peptide hormone processing. 
Introduction 
 Hundreds of microRNAs (miRNAs), a class of endogenous 21-25 nucleotide small RNAs 
that modulate gene expression by binding complementary sequences in the 3’-untranslated 
regions (3’-UTRs) of their target mRNA transcripts36, are expressed in the mature mammalian 
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brain37-40 and are thought to be involved in synapse development and plasticity41. The 
biogenesis of mature miRNAs is characterized by successive RNA cleavage events in which 
long primary miRNA (pri-miRNA) transcripts are processed into shorter preliminary miRNA 
(pre-miRNA) hairpins, exported from the nucleus, and cleaved into ~22 nt duplex RNAs prior 
to being loaded into RNA-induced silencing complexes (RISCs)36. Each RISC contains an 
Argonaute protein (AGO1-4 in human and mouse), and a miRNA42. The RISC then interacts 
with the target mRNAs through base pairing interactions specified by the miRNA, and either 
represses translation or induces mRNA degradation. AGO2, the only catalytically active AGO 
family member in humans and mice, has endonuclease (‘slicer’) activity and the ability to 
cleave target mRNAs36. 
 Exposure to drugs of abuse such as cocaine triggers persistent cellular and molecular 
changes in the limbic regions of the brain that process reward. The limbic system, in particular 
the striatum, is considered the epicenter of the long-term molecular and morphological 
changes that underlie addiction79. The ventral striatum (nucleus accumbens) is considered the 
primary striatal subregion with limbic functions. Neurons can modulate gene expression with 
subcellular precision; polyribosomes and mRNAs are found at the base of dendritic spines and 
are involved in localized protein synthesis43,44. Both AGO2 and DICER, an RNase III enzyme 
required for miRNA biogenesis, have been localized to dendritic spines47. Emerging evidence 
supports an autonomous role for individual synapses in the local control of protein translation 
coupled to neuronal excitation41,45. 
 Data from broad expression studies using microarray technology and from focused 
single-gene approaches indicate that cocaine exposure elicits widespread changes in the 
transcriptional landscape87. Several recent studies have begun to investigate the role of AGO2 
and miRNAs in the biochemical, molecular, and behavioral response to cocaine123-126. For 
example, qPCR and in situ analysis of specific bioinformatically-determined miRNAs identified 
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let-7d, miR-124, and miR-181a as cocaine-regulated in rats123. Two studies by the Kenny group 
identified induction of miR-132 and miR-212 in dorsal striatum after 7 days of cocaine self-
administration in rats and implicate miR-212 in the behavioral and motivational response to 
cocaine through CREB, MeCP2, and BDNF signaling124,125. In addition, Schaefer et al. identified 
an overlapping subset of cocaine-induced and AGO2-knockdown-depleted miRNAs in D2 
dopamine receptor (Drd2) expressing neurons of the NAc, and showed a reduction in cocaine 
self-administration when AGO2 is depleted from Drd2 neurons126. Consistent with these 
findings, we observed cocaine-induced increases in Ago2 mRNA levels upon performing RNA-
Seq (JEE-M et al. in preparation). Together, these studies provide evidence that miRNA-
mediated gene regulation plays an important role in cocaine-related changes in 
neurotransmission and behavior. However, all of these studies were targeted to a small 
number of candidate miRNAs or used microarrays, which suffer from issues of cross-
hybridization, higher background signal, lower dynamic range, and lack the ability to identify 
unknown miRNAs3, and therefore do not provide a complete picture of cocaine-induced 
changes in miRNA levels. 
 Here, we have more closely examined the role of AGO2 and miRNAs in response to 
chronic cocaine exposure. First, we confirmed synaptic Ago2 mRNA and protein expression in 
the striatum and increased expression upon chronic cocaine exposure. We also determined 
the repertoire of miRNAs expressed in total nucleus accumbens (NAc) tissue lysates and 
purified striatal postsynaptic densities (PSDs) harvested from saline- and cocaine-treated mice. 
This led to the identification of a subset of cocaine-regulated miRNAs in whole tissue and at 
the synapse, and the characterization of miRNAs by degrees of synaptic enrichment and 
depletion. We also identified mRNAs that are potentially targeted by the differentially 
expressed miRNAs, and validated cocaine-induced changes in protein levels for several of the 
identified targets. These data provide an overview of the global regulation and synaptic 
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enrichment of miRNAs in response to cocaine. 
Results 
Cocaine regulates striatal AGO2 
 To assess whether AGO2 protein was present at striatal synapses, we subjected adult 
mouse striatum to subcellular fractionation (Fig. 2.1A). Strong enrichment of NR2B, an NMDA 
receptor subunit, in the PSD fraction, and depletion of Synaptophysin, a presynaptic protein, 
verified the success of the preparation131-133. The ER lumenal protein BiP showed strong 
enrichment in the ER and Golgi fraction. βIII-tubulin was most abundant in the cytoplasmic 
fractions. Likewise, the striatally-enriched cytoplasmic protein DARPP32134 was highly enriched 
in soluble fractions and was absent from synaptic fractions. As expected, AGO2 was enriched 
in the ER/Golgi fraction and present in the cytoplasmic fractions. Consistent with prior studies 
demonstrating synaptic localization of AGO2 in hippocampus and frontal cortex47,135, our data 
indicate that AGO2 was present in striatal PSDs (Fig. 2.1A). 
 We next used quantitative-PCR to examine whether chronic cocaine administration 
affected Ago2 mRNA expression in the ventral striatum and found a significant increase in the 
level of Ago2 mRNA following cocaine exposure (Fig. 2.1B). We then determined the impact of 
chronic cocaine on AGO2 protein levels at the PSD. Striata (dorsal and ventral) and medial 
prefrontal cortices (mPFCs) from 12 cocaine-treated and 12 saline-treated wild-type male 
C57BL/6 mice were pooled and subjected to subcellular fractionation. Levels of AGO2 and βIII-
tubulin in PSDs purified from striata and mPFCs were assessed by quantitative Western 
blotting. We observed a 24% increase in synaptic AGO2 protein after cocaine treatment in the 
striatum, but not the mPFC (Fig. 2.1C,D). Together these results indicate that AGO2 is localized 
to the striatal PSD and increases after cocaine treatment. Because up-regulation of AGO2 was 
specific to the striatum, we chose to focus our subsequent analyses on this brain region.  
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Figure 2.1 Subcellular fractionation 
(A) Wildtype mouse striata were subjected to subcellular fractionation. Aliquots containing equal 
amounts of protein (10µg; 5µg, PSD) were fractionated by SDS-PAGE, transferred, and analyzed by 
Western blot. NR2B, AGO2, and Synaptophysin were visualized from one gel; BiP, βIII-tubulin, and 
DARPP32 were visualized from an identical gel. PSD, postsynaptic density. (B) Total NAc RNA from adult 
male mice treated with saline or cocaine (4 per group) was analyzed by qPCR; Ago2 mRNA expression 
was normalized to GAPDH. (C,D) PSDs purified from the striata (C) and PFCs (D) of saline (S)- and cocaine 
(C)-treated mice were fractionated by SDS-PAGE. AGO2 levels were normalized to βIII-tubulin by 
densitometry for the varying amounts of protein loaded; plot shows average C/S ratio for AGO2. 
Significance was tested by the 2-tailed Student's t-test with unequal (B) or equal (C,D) variance. *P < 
0.05; **P < 0.01. 
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The nucleus accumbens and purified striatal PSDs share abundant microRNAs 
 Given the synaptic localization and cocaine responsiveness of AGO2 protein, we 
hypothesized a role for AGO2 and miRNAs in regulating mRNA stability or translation at the 
striatal PSD in response to cocaine. To explore this idea, we used next-generation sequencing 
to analyze the global miRNA expression profiles in both NAc total lysates and purified striatal 
PSDs. For the NAc lysates, we sequenced 2.53 and 4.46 million reads from the saline and 
cocaine samples, respectively (Table 2.S1). We also generated 3.67 and 4.60 million reads from 
the striatal PSD saline and cocaine samples, respectively (Table 2.S1). After removing the 3’ 
linker sequence, reads ranging from 18-30 nt were aligned to the miRBase database (version 
16)136,137 using Bowtie (version 0.12.7)24 to identify and assess the abundance of known 
miRNAs. 
 We generated pairwise scatter plots to compare expression of each mature miRNA (as 
a percentage of total reads) across all four samples (Fig. 2.2A). The two NAc total lysate 
samples correlated more closely with each other (R2 = 0.97) than with either striatal PSD 
sample (R2 = 0.90-0.93). The converse was also true, with striatal PSD miRNAs exhibiting a 
higher correlation to one another (R2 = 0.97) than to the NAc samples. For both the total tissue 
lysates and the PSDs, a handful of individual miRNAs appeared to be cocaine-regulated; 
cocaine treatment did not cause widespread alterations in the global miRNA profile. 
 While the total tissue lysate and purified PSD expression profiles differed, the most 
highly expressed miRNAs were largely identical; 11 of the 15 most abundantly sequenced 
miRNAs in both groups were the same (Fig. 2.2B,C). Of note, a number of miRNAs known to be 
brain-specific or neurally-enriched, such as miR-9, miR-30, miR-127, miR-138, miR-181, and let-
737-40, were very abundant in these samples. 
 We detected one or more reads mapping to a total of 500 (74%) of the 672 mouse pre-   
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Figure 2.2 High-throughput sequence analysis of NAc and PSD miRNA 
(A) Pairwise scatter plots of miRNA expression data for NAc lysate and striatal PSD libraries (Saline and 
Cocaine) prepared from adult mouse; shown as log10(normalized miRNA frequency) per sample. R2 
values were calculated by least squares best fit. Expression data for the 15 most abundant miRNAs in 
NAc lysates (B) and striatal PSDs (C) are shown as reads (adjusted for equal total reads per sample). The 
miRNAs in black italics are highly expressed in both NAc and PSD; miRNAs in red italics are highly 
expressed only in that sample. 
 
 
 
Classification of miRNAs detected by RNA-Seq 
 miRBase v16 All data NAc lysates Striatal PSDs 
pre-miRNAs 672 500 (280) 475 (242) 476 (264) 
mature miRNAs 1055 771 (342) 718 (283) 732 (312) 
miRNA families 253 222 (159) 214 (137) 216 (147) 
miRNAs in families 502 410 (266) 392 (230) 394 (253) 
 
Table 2.1 Classification of miRNAs detected by RNA-Seq 
Number of pre-miRNAs, mature miRNAs, miRNA families, and miRNAs in families detected by RNA-Seq 
at one or more reads and 100 or more reads (in parentheses). 
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miRNAs annotated in miRBase, of which 475 and 476 miRNAs were detected in the NAc and 
striatal PSD libraries, respectively (Table 2.1). We set a lower limit of 100 reads per miRNA for 
further analysis since we found that reliable qPCR validation of changes necessitated this level 
of expression. Although this read requirement decreased the diversity of miRNAs considered 
for further analysis, the miRNAs meeting the expression cut-off account for 99.7% and 99.8% 
of all reads in the NAc and striatal PSD libraries, respectively. A summary of the individual 
miRNAs and miRNA families identified in these experiments is presented in Table 2.1. 
Cocaine modulates expression of ventral striatum microRNAs 
 There were 283 mature miRNAs detected with at least 100 reads in both NAc lysate 
libraries (Table 2.1); 10% of these miRNAs exhibited at least a 1.5-fold change in expression, 
with 16 miRNAs up-regulated and 13 down-regulated after cocaine treatment. The NAc total 
lysate miRNAs that exhibit the largest changes in expression following cocaine are shown in 
Fig. 2.3A. The regulated miRNAs were generally of low- to moderate-abundance, detected at a 
level between 100 and 1000 reads. One notable exception, miR-29b, was among the 15 most 
abundantly expressed miRNAs in the NAc (Fig. 2.2B). 
 We used qPCR to validate cocaine-induced changes in several of the most highly 
regulated miRNAs and to validate RNA-Seq data for miRNAs known to be brain-enriched or 
synaptically-relevant. Commercially available probes were used for qPCR; these probes 
measure only one mature miRNA product, which did not always correspond to the most 
abundantly sequenced product due to 3’-end heterogeneity (Fig. 2.4). Nevertheless, strong 
agreement across the two methods (r = 0.68) was observed when the cocaine/saline ratios 
obtained by qPCR and RNA-Seq were plotted (Fig. 2.3B). Importantly, inter-platform 
agreement was consistent over a broad range of overall expression levels. 
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Figure 2.3 Cocaine-regulated miRNAs in NAc total lysates 
(A) NAc lysate libraries (Saline and Cocaine) analyzed by high-throughput sequencing of miRNAs. The 
eight most cocaine down- and up-regulated miRNAs detected at >100 reads are shown as adjusted 
reads (equal total reads per sample) on log10 scale. The number above the bars indicates fold change. (B) 
Pairwise scatter plot comparing log10 ratio of Coc/Sal expression for selected miRNAs in NAc tissue 
lysate as computed from RNA-Seq data (vertical axis) and qPCR data (horizontal axis). Size of circle is 
proportional to average RNA-Seq expression value. Pearson’s Coefficient represents the linear 
correlation coefficient, r. 
  
30 
 
 
Figure 2.4 3’-end heterogeneity and varying RNA-Seq read abundance 
Expression data across all samples are shown as reads (adjusted for equal total reads per sample) for 
sequences mapping to miR-132 and miR-143. Arrowhead () marks annotated mature miRNA sequence 
from miRBase version 16. Commercially available qPCR primers amplify sequence marked by 
arrowhead. 
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Cocaine regulates microRNAs in striatal PSDs 
 A specific subset of mRNAs is transported along dendrites and local protein synthesis 
occurs in stimulated dendritic spines, altering the components of the synapse43,44. Since AGO2 
protein is localized to the PSD and its levels at the PSD increased following chronic cocaine 
exposure, we determined whether any PSD localized miRNAs were responsive to cocaine. 
There were 312 mature miRNAs detected at 100 reads or more in both striatal PSD libraries 
(Table 2.1); 11% of these miRNAs exhibited at least a 1.67-fold change in expression, with 4-
times as many miRNAs down-regulated (28) as up-regulated (7) after cocaine treatment. Fig. 
2.5A shows those striatal PSD miRNAs with at least 100 reads that demonstrated the largest 
change in expression following cocaine. Similar to what was observed for the NAc miRNAs, the 
cocaine-regulated PSD miRNAs were generally of low- to medium-abundance, detected with 
100 to 10,000 reads. 
 We again turned to qPCR to confirm responses observed with RNA-Seq. A comparison 
of the ratios of cocaine/saline measured by RNA-Seq and qPCR showed a high degree of 
concordance between the two techniques (r = 0.76) (Fig. 2.5B). Cross-platform agreement 
spanned a very broad range of expression levels, as seen in NAc lysates. 
Synaptically-enriched microRNA families 
 To determine the subset of miRNAs that are enriched or depleted at the synapse, we 
calculated the relative abundance of each miRNA in all four samples. We then computed the 
average abundance of each miRNA in the two NAc lysate and striatal PSD samples, and 
calculated the log10 ratio of the PSD average over the NAc average. The miRNAs with higher 
PSD-to-NAc lysate ratios are synaptically-enriched (Fig. 2.6), while those with lower ratios are 
synaptically-depleted (Fig. 2.7). Z-scores of relative expression were calculated for each 
sample and the data displayed as heat maps (Fig. 2.6A,B). 
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Figure 2.5 Cocaine-regulated miRNAs in striatal PSDs 
(A) Striatal PSD libraries (Saline and Cocaine) analyzed by high-throughput sequencing of miRNAs. The 
eight most cocaine down- and up-regulated miRNAs detected at >100 reads are shown as adjusted 
reads as described in Fig. 3. (B) Pairwise scatter plot comparing log10 ratio of Coc/Sal expression for 
selected miRNAs in striatal PSDs as computed from RNA-Seq data (vertical axis) and qPCR data 
(horizontal axis) as described in Fig. 2.3. 
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Figure 2.6 Identification of miRNA families enriched at the PSD 
(A) Normalized miRNA frequency data for saline- and cocaine-treated NAc lysate and striatal PSD 
libraries of wildtype mice were calculated; heat map is sorted by decreasing average PSD 
frequency/NAc frequency ratio. Z-score was computed on normalized miRNA frequency across all 
samples. Blue indicates low expression and yellow indicates high expression. (B) Expansion of heat map 
showing top PSD-enriched miRNAs. Text color indicates miRNA families with 2 or more family members 
appearing in the list. 
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 Of the 672 annotated murine miRNAs, 75% (502) can be grouped into 253 families 
based on sequence homology in the ‘seed region’ (nts 2-8 at the 5’-end of the miRNAs) and 
the observation that these miRNAs are often functionally redundant36. We detected expression 
of at least one member of 222 (88%) of the 253 annotated miRNA families, with 159 families 
expressed at 100 reads or more (Table 2.1). Strikingly, several of the synaptically-enriched 
miRNAs we identified were members of the same family, as indicated by text color in Fig. 2.6B. 
All 5 members of the miR-8 family (miR-141, miR-200a, miR-200b, miR-200c, and miR-429) were 
synaptically-enriched. The same was true for the miR-7 and miR-142 families. The mouse 
genome contains 12 loci encoding members of the let-7 family, three of which were 
synaptically-enriched (Fig. 2.6B). In contrast, we did not observe family enrichment in the 
subset of PSD-depleted miRNAs (Fig. 2.7). 
PSD-localized, cocaine-regulated microRNAs target a functionally-related subset of 
mRNAs 
 To provide insight into the role of the cocaine-regulated miRNAs, we performed a 
computational search for potential target mRNAs. First, we compiled a list of 1,041 
dendritically- and synaptically-localized mRNAs reported in the literature138-143 (Table 2.S4). 
424 of those mRNAs were PSD-enriched in rat forebrain by microarray143, and this subset of 
synaptically-localized genes (Table 2.S4) was cross-referenced with the putative miRNA target 
genes identified by analysis using the miRanda microRNA target prediction algorithm144,145. 
Briefly, each predicted miRNA binding site in the 3’-UTR of a given gene has a pre-computed 
mirSVR score; this value directly correlates with the extent of mRNA down-regulation 
predicted by miRNA binding, and the composite score for each gene in Fig. 2.8 represents the 
sum of all cataloged mirSVR scores across the queried miRNAs145. 
 We performed target prediction on the 16 PSD-localized cocaine-regulated miRNAs   
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Figure 2.7 miRNAs depleted at the PSD 
(A) High-throughput sequencing data for saline- and cocaine-treated NAc lysates and striatal PSDs of 
wildtype mice; normalized miRNA frequency was calculated and heat map is sorted by decreasing 
average PSD frequency/NAc frequency ratio (as in Fig. 2.6). Z-score was computed on normalized 
miRNA frequency across all samples. Blue indicates low expression and yellow indicates high 
expression. (B) Expansion of heat map showing top PSD-depleted miRNAs. Text color indicates miRNA 
families with more than two miRNAs appearing in the list. 
  
 
Figure 2.8 Target prediction for cocaine-regulated miRNAs  
The 16 most cocaine-regulated striatal PSD miRNAs from Fig. 4.6 were subjected to bioinformatic target prediction using miRanda. The list of potential 
target mRNAs was cross-referenced with the 424 PSD-enriched mRNAs identied by Suzuki et al. 2007 (Table S4) and sorted by ascending mirSVR score.  
symbols show presence of predicted miRNA binding site in 3’-UTR of target gene; number of  signs denotes number of predicted miRNA binding sites. 
The 36 target genes shown were run through gene ontology (GO) analysis using DAVID; colored boxes indicate enriched GO functions with P < 0.05.  
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depicted in Fig. 2.5A. A subset of the list of synaptically-localized predicted target genes for 
the cocaine-regulated striatal-PSD miRNAs sorted by mirSVR score is shown in Fig. 2.8. A 
number of the identified target genes were predicted to have multiple binding sites for a 
given miRNA in their 3’-UTR (depicted by the number of Æ symbols) and the majority of the 
predicted target genes had putative binding sites for both up- and down-regulated miRNAs.
 We carried out gene ontological analysis using DAVID28,146,147 to investigate the 
functional properties of the identified target genes. The colored boxes next to the genes in 
Fig. 2.8 show the enriched gene ontological categories (P < 0.05). Most of the enriched 
categories (cell junction, regulation of synaptic transmission, calcium ion binding, 
dendrite/neuron projection, cell-cell signaling, cytoskeleton, phosphate metabolic process, 
transmembrane, growth factor binding) are processes generally linked to synaptic plasticity, 
learning, and memory. 
Identified target genes exhibit differential expression at striatal synapses after 
cocaine 
 Schematic drawings for Ntrk2, E-cadherin, Mtdh and Pcsk2, potential target genes of 
cocaine-regulated synaptic miRNAs (Fig. 2.9), depict the sites within their annotated 3’-UTRs 
that are predicted to bind up- and down-regulated miRNAs. Since these synaptically-enriched 
transcripts may interact with multiple regulated miRNAs, the direction of cocaine-mediated 
changes in synaptic protein levels are difficult to predict. 
 We used quantitative Western blotting to investigate the effect of cocaine 
administration on the protein level of several potential target genes of cocaine-regulated 
synaptic miRNAs (Fig. 2.9). One identified target gene is Ntrk2 (also known as TrkB), a member 
of the neurotrophin receptor tyrosine kinase family, which binds brain-derived neurotrophic 
factor (BDNF) and is critically involved in the process of activity-dependent synaptic plasticity 
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and long-term potentiation (LTP)148. The Ntrk2 3’-UTR is targeted by four miR-8 family members 
(miR-200a, miR-200b, miR-200c, and miR-429), which are down-regulated by cocaine, and by 
miR-33 and miR-130b, which are up-regulated by cocaine (Fig. 2.8). The level of synaptic TRK 
protein increased 18% in the striatum after chronic cocaine administration (Fig. 2.9A). 
 Similarly, synaptic expression of Metadherin (MTDH), encoded by Mtdh, the top 
synaptically-regulated miRNA target gene (Fig. 2.8), increased to 142% of the saline level after 
chronic cocaine treatment (Fig. 2.9B). Mtdh is targeted by miR-183 and four miR-8 family 
members, which are down-regulated by cocaine, and by miR-16, miR-32, miR-33, miR-130b, and 
miR-153, which are up-regulated by cocaine (Fig. 2.8). While not a direct target of the 
identified cocaine-regulated synaptically-localized miRNAs, E-cadherin (also known as Cdh1 or 
ECAD) expression is controlled by transcriptional repressors (ZEB1 and ZEB2) which are directly 
targeted by members of the miR-8 family of miRNAs149, and by several other miRNAs which are 
down-regulated by cocaine and by a number of miRNAs which are up-regulated by cocaine 
(Fig. 2.9B). Two forms of ECAD were detected at the synapse by Western blot (Fig. 2.9B). The 
105 kDa major band is mature ECAD (black arrow) and the higher molecular weight band 
represents proECAD150,151. The level of mature ECAD decreased to 68% of the saline level 
following chronic cocaine. 
 The prohormone convertase PC2 (also known as Pcsk2) was also identified in our 
bioinformatic analysis as a potential target of the cocaine-regulated miRNAs. Pcsk2 is targeted 
by three miR-8 family members and miR-370, which are down-regulated by cocaine, and by 
miR-32 and miR-218, which are up-regulated by cocaine (Fig. 2.8). Several forms of PC2 were 
detected at striatal PSDs by Western blot (Fig. 2.9C). The smaller molecular weight band 
represents mature PC2, the middle band represents proPC2 and the upper band is the size of 
preproPC2152, indicative of dendritic synthesis and processing. When normalized to βIII-   
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Figure 2.9 Validation of target predictions  
(A,B) PSDs purified from the striata of saline (S)- and cocaine (C)-treated mice were fractionated by SDS-
PAGE; three different amounts of protein were analyzed to establish response linearity. Levels for pan-
TRK (a), ECAD (), and MTDH (b), and PC2 (), proPC2 (), and preproPC2 () (C) were normalized to 
βIII-tubulin by densitometry for the varying amounts of protein loaded; plot shows average C/S ratio. 
Based on published reports, the higher molecular weight band (~120 kDa) above the major 105 kDa 
ECAD band corresponds to the precursor, proECAD ()150,151. For PC2, the smaller molecular weight 
band represents mature PC2 (), the middle band represents proPC2 () and the upper band is the size 
of preproPC2 ()152. Schematic drawings represent mRNAs of indicated genes; open reading frame 
(ORF) is gray, 3’-UTR is striped, arrowheads show miRanda predicted miRNA binding sites for miRNAs 
up-regulated () or down-regulated () after cocaine at PSD. Significance was tested by the 2-tailed 
Student's t-test with equal variance. *P < 0.05; **P < 0.01. 
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tubulin, mature PC2 and proPC2/preproPC2 increased significantly, 67% and 61%, 
respectively, after cocaine treatment. 
Discussion 
 The role of miRNAs in response to drugs of abuse is largely unknown. Here, we used 
deep sequencing to identify miRNAs that are differentially regulated in response to cocaine 
exposure, both in purified NAc tissue and at striatal synapses. This catalog of synaptically 
enriched and cocaine-regulated miRNAs provides new insight into the molecular mechanisms 
of the cocaine-response and serves as a resource for future studies. 
 Intriguingly, many (18) of the synaptically-enriched miRNAs we identified are encoded 
in miRNA clusters – precursor transcripts that contain multiple miRNAs – or are members of 
the same miRNA families. Moreover, the expression patterns of the clustered miRNAs are 
similar to one another. Particularly strong examples include the two clusters encoding miR-8 
family members (miR-429/200a/b and miR-141/200c), the cluster encoding let-7 family 
members (let-7f/miR-98), and clusters miR-1/133a, miR-182/96/183, and miR-216a/217 (Fig. 
2.10). This indicates that many of the miRNAs we identified are coordinately regulated by 
virtue of being encoded in clusters and potentially control the same set of mRNA targets as 
they share the same seed sequences. 
 It is well established that the growth and remodeling that occur in dendritic spines 
following synaptic activity require de novo protein synthesis, and that blocking protein 
synthesis attenuates formation of long-term memory41. The ability to modulate the synthesis 
of a subset of synaptic proteins affords neurons the capacity to integrate and fine-tune 
extracellular cues with subcellular resolution, in individual dendrites or at specific synapses153. 
MicroRNAs represent ideal candidates for regulating local translation of specific mRNAs at the 
synapse. It is therefore intriguing that we observed both increased levels of synaptically   
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Figure 2.10 Analysis of miRNA clusters and families  
Heat map shows expression of striatal PSD-enriched miRNAs and accompanying members of their 
genomic cluster; “chr” denotes chromosomal location of each miRNA cluster. Normalized miRNA 
frequency was calculated from high-throughput sequencing data; Z-score was computed on 
normalized miRNA frequency across all samples. Blue indicates low expression and yellow indicates 
high expression. Text color identifies miRNA families with two or more miRNAs; bold text indicates 
presence in PSD-enrichment list from Fig. 5; gray italic text indicates miRNAs not enriched at striatal 
PSD and/or not belonging to listed miR families.  
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Figure 2.11 Comparison of data for striatum and cortex/hippocampus 
(A) Pairwise scatter plot comparing miRNA synaptic enrichment ratios from Lugli et al., 2008 (adult 
mouse cortex and hippocampus; measured by microarray) with RNA-Seq data (adult mouse striatum) 
from these experiments. Horizontal axis, data from Lugli et al., 2008 computed as ratio of PSD (Syn)/total 
tissue (Tot) expression; vertical axis, data from RNA-Seq computed as PSD/NAc lysate ratio of average of 
saline and cocaine expression levels for adult mouse striatal PSD and NAc lysate. Blue circles were 
identified as cocaine-regulated and/or were assayed by qPCR, green circles indicate miRNAs enriched at 
striatal PSDs by RNA-Seq, red circles indicate miRNAs depleted at striatal PSDs by RNA-Seq, and gray 
circles represent all other miRNAs. Size of circle is proportional to average RNA-Seq expression value. (B) 
Synaptosomal enrichment and depletion categories for miRNAs from Siegel et al., 2009 as determined 
by microarray analysis of rat forebrain samples. Heat map shows high-throughput sequencing data for 
saline- and cocaine-treated NAc lysates and striatal PSDs of wildtype mice; normalized miRNA frequency 
was calculated and Z-score was computed on normalized miRNA frequency across all samples. Blue 
indicates low expression and yellow indicates high expression. 
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localized AGO2 protein and altered levels of specific miRNAs upon cocaine exposure. These 
observations indicate that modulations in miRNA-mediated gene regulation play an important 
role in the response to cocaine. Programmed changes in miRNA levels may result in specific 
changes in the stability and/or the translation rate of target mRNAs at the synapse. 
 We identified several miRNAs that were synaptically enriched or depleted (Fig. 
2.6B,2.7B). A comparison of our data to earlier microarray experiments performed in adult (2-
month old) mouse cortex and hippocampus135 (Fig. 2.11A) revealed significant overlap. 
Notably, 4 of the 5 miR-8 family members (miR-200a/b/c/429) are highly enriched in both 
datasets. Additionally, miR-182 and miR-183 are highly PSD-enriched in both datasets while 
miR-126, miR-143, miR-145, miR-150, and miR-451 are synaptically depleted in both datasets 
(Fig. 2.11A). We also observed strong agreement between our data and a second microarray 
study that identified synaptosomally-enriched and depleted miRNAs from rat P15 total 
forebrain samples52. In both datasets, miR-219-5p, miR-21, miR-377, miR-98, miR-376b, miR-218, 
miR-7a/b, and miR-29a are synaptosomally- or PSD-enriched, while miR-143, miR-145, and miR-
150 are depleted (Fig. 2.11B). The high degree of concordance between these three datasets, 
which used different experimental platforms and strikingly different samples, may reflect the 
prevalence of glutamatergic synapses and other features common to these brain regions. 
 The increased levels of AGO2 and altered levels of specific miRNAs at the synapse in 
response to cocaine strongly suggest that these factors play a role in controlling translation of 
localized mRNAs. To explore this, we identified potential mRNA targets from a set of PSD-
enriched mRNAs143 (Fig. 2.8). Due to the fact that most mRNAs we identified are predicted to 
be targeted by many of the regulated miRNAs, it was difficult to predict whether translation of 
the targets would increase or decrease in response to cocaine. Nonetheless, we confirmed 
changes in protein levels for three predicted targets (TRKB, MTDH, and PC2) and one indirect 
target (ECAD) upon exposure to cocaine. One of the validated targets, TRKB (NTRK2), has also 
44 
 
been shown to increase in the NAc of rats after chronic cocaine self-administration154, and 
TRKB-BDNF signaling in the NAc may modulate behavioral responses to cocaine155. 
Importantly, several other predicted targets have been implicated in various aspects of the 
cocaine response156-158. 
 Recent studies have demonstrated the importance of miRNAs in the pathophysiology 
of several neuropsychiatric disorders and mental retardation syndromes157,158, including 
schizophrenia56-58,159, bipolar disorder, Fragile X mental retardation160-162, Rett syndrome61, 
Alzheimer’s disease, Parkinson’s disease163, and Huntington’s disease55. A number of the 
cocaine-responsive miRNAs identified in this study are important in controlling dendritic 
morphology; these miRNAs, and many others, may contribute to long-lasting forms of drug-
mediated synaptic plasticity through control of regulatory pathways that modulate changes 
to the actin cytoskeleton, neurotransmitter metabolism and peptide hormone processing. It is 
likely that the miRNAs we identified are but one aspect of an exquisitely complex regulatory 
system which includes dendritic mRNA trafficking and excitation-coupled modulation of 
translation and protein phosphorylation to fine-tune translation of synaptically-localized 
miRNAs. As the breadth of information about the molecular changes that occur in the brain in 
response to cocaine and other drugs of abuse increases, the importance of integrating these 
data in a meaningful and biologically informative way becomes increasingly clear. 
Methods 
Cocaine treatment of mice 
 Adult wild-type C57BL/6 mice (Jackson Laboratories, Bar Harbor, Maine; 2-5 months 
old) were used for these experiments. All mice were allowed to acclimate to the colony for at 
least one week before handling or injections. Mice were kept in the University of Connecticut 
Health Center animal facility on a 12 h light/dark cycle (lights on 7:00 am to 7:00 pm) and 
45 
 
handled in accordance with University of Connecticut Health Center Institutional Animal Care 
and Use Committee guidelines. To reduce stress from handling during the injections, animals 
in all groups were handled for 1min/animal/day for 2-3 days prior to the start of injections. 
During injections, animals were brought into the behavior room to acclimate to the new 
environment for 45-60 minutes each day before the beginning of experiments. 
 For these studies, we used two slightly different cocaine injection paradigms, both of 
which have been shown to produce robust locomotor sensitization. For all experiments, 
animals were given a saline or cocaine injection and had their locomotor activity monitored 
for the subsequent 45 minutes. In the experiments in which RNA from NAc lysates was used 
for miRNA-Seq library preparation, animals were given injections of 20 mg/kg cocaine or saline 
(10 ml/kg) intraperitoneally for 7 days. Our group and others have demonstrated the efficacy 
of this method at eliciting robust locomotor sensitization98,164. For all other experiments (both 
RNA and protein), animals received a lower dose of cocaine (10 mg/kg) on the first and last 
(7th) day, with the standard 20 mg/kg cocaine dose on days 2-6165,166. The extent of locomotor 
sensitization was taken as the ratio of activity on day 7/day 1166. We chose to switch to this 
method because it provided a clearer distinction between those animals that had sensitized 
and those that did not. Protein biochemistry from our laboratory has shown no biochemical 
differences between sensitized animals from the two paradigms (DDK, unpublished 
observations). Neither tissue nor data from these different treatment paradigms were pooled. 
For all experiments, animals were sacrificed 24 hours after the final injection. 
Whole tissue lysate preparation and subcellular fractionation 
 Adult male mouse ventral striatum (nucleus accumbens, NAc) punches were 
harvested. For whole tissue protein studies, samples were sonicated and boiled in 1% SDS, 
50mM TrisHCl [pH 7.4], 5mM EDTA, 50mM NaF, 2mM sodium orthovanadate, 1mM PMSF, and 
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protease inhibitor cocktail as described133. Total RNA from tissue lysates for individual mice 
was prepared from freshly dissected tissue with TRIzol (Invitrogen) following the 
manufacturer’s instructions, except that isopropanol precipitation was carried out overnight at 
-20°C with 2 ethanol washes instead of one. 
 For subcellular fractionation, whole striata (40 mg wet weight/mouse) or medial 
prefrontal cortices (mPFC) (30 mg/mouse) from 12 identically-treated male mice were pooled, 
homogenized and fractionated by differential centrifugation followed by sucrose gradient 
centrifugation. After extraction of the PSD-enriched fraction with 0.5% Triton X-100, PSDs were 
pelleted and subjected to Western blot analysis as described98,133. The protocol is similar to 
that of Lugli et al.135 and was modified to protect against RNA degradation as follows: all rotors, 
homogenizers, pestles, and ultracentrifuge tubes were rinsed with RNaseZAP (Applied 
Biosystems) and DEPC water and air dried prior to use; fractionation buffers were prepared 
using DEPC water and were treated with RNASecure (1:25 dilution from stock; Applied 
Biosystems) at 60°C for 10 min; aliquots of different subcellular fractions were diluted into 
TRIzol for preparation of total RNA as described above. 
Small RNA cloning and sequencing 
 Small RNA sequencing libraries were prepared following the manufacturer’s 
instructions for the Small RNA Sample Prep Kit (Illumina). Total RNA used for NAc tissue lysate 
library preparation was pooled in equal parts from RNA isolated from 8 male mice from each 
treatment group. One saline and one cocaine NAc lysate library were prepared from the 
pooled RNA and these are referred to as NAc lysate saline and cocaine libraries. Total RNA used 
for striatal postsynaptic density (PSD) library preparation was isolated as outlined above from 
the pooled striata of 11 mice (7 male, 4 female) from each treatment group; these libraries are 
referred to as striatal PSD saline and cocaine libraries. Small RNAs of 18-35 nt were gel-purified 
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from 1 µg of pooled total RNA. Eluted RNAs were ligated to 5’ and then to 3’ adaptors with 
RNA ligase, with gel purification following each ligation. RNAs were reverse transcribed and 
cDNAs were PCR-amplified for 16 cycles. PCR products were purified on a non-denaturing 
acrylamide gel and sequenced on the Illumina Genome Analyzer IIx for 50 (NAc lysate libraries) 
or 40 (striatal PSD libraries) cycles. 
Small RNA genomic analysis 
 Sequences were extracted from image files using Firecrest and Bustard. The 3’ adaptor 
sequences were trimmed from the reads, and reads 18-30 nt in length were aligned to all 
annotated mouse microRNAs from miRBase (www.mirbase.org; version 16) with Bowtie24 
(bowtie-bio.sourceforge.net; version 0.12.7); only perfectly aligning reads were considered for 
miRNA expression level analysis. A custom Perl script was used to calculate the number of 
reads aligning to each specific miRNA gene and data were normalized by the total number of 
reads obtained in that sequencing run. A cut-off of 100 reads or more for an individual miRNA 
was required for it to be included in further expression analyses. 
 To identify reads mapping to a variety of non-coding genes and repetitive elements, 
the remaining non-miRNA sequences were aligned to the Rfam database (rfam.sanger.ac.uk; 
version 10.0), the Repbase database (www.girinst.org/repbase/index.html; version 16.01), and 
NONCODE (noncode.org; version 2.0). We subsequently mapped the remaining reads to the 
mouse transcriptome, including exons, introns, and exon-exon junctions annotated on the 
UCSC genome browser (genome.ucsc.edu; mm9; NCBI Build 37) as the following tracks: UCSC 
Genes, RefSeq Genes, Vega Protein Coding Annotations, and Ensembl Gene Predictions. 
Finally, the remaining reads were aligned to the mouse genomic sequence (genome.ucsc.edu; 
mm9; NCBI Build 37). All of these alignments were performed using Bowtie and allowing 1-
mismatch. Alignment data are shown in Fig. 2.12.  
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Figure 2.12 Identification of mapped sequences 
After trimming 5’ and 3’ adaptors from extracted sequences for all four libraries, those between 18 and 
30 nt in length were aligned to miRBase annotated mouse microRNAs using Bowtie24 (version 0.12.7); 
perfect alignment was required. Remaining non-miRNA sequences were aligned to non-coding and 
repetitive elements annotated in the Rfam, Repbase, and NONCODE databases, and then to the mouse 
transcriptome (exons, introns, exon-exon junctions), and mouse genome. These non-miRNA alignments 
were performed permitting 1-mismatch. The percentage of the total reads mapped to each category is 
shown graphically in the pie-chart and numerically in tabular form. 
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 Importantly, the trimmed reads were also aligned to miRBase allowing 1- or 2- 
mismatches. Neither the overall expression pattern nor the list of the most cocaine-responsive 
miRNAs changed significantly when allowing for more mismatches (JEE-M, unpublished 
observations). Read numbers presented in this paper were calculated from the 0-mismatch 
alignment. 
Generation of heat maps 
 Normalized miRNA frequency across all 4 sequenced libraries was calculated; 
expression in one sample of 100 reads or more was required. Z-scores were computed from 
frequency data using the following equation: (x - µ)/σ; x, sample frequency; µ, mean across all 
samples; σ, standard deviation across all samples. Blue indicates low expression and yellow 
indicates high expression; heat maps were generated using Java Treeview software 
(sourceforge.net/projects/jtreeview/files). 
Target gene prediction 
 MicroRNA target genes were identified using miRanda144,145 (www.microrna.org; 
August 2010 release). Prediction scores were computed using the miRanda database of highly 
conserved target sites with good mirSVR scores145. We chose this database because programs 
requiring target conservation across a broad range of species are more stringent than those 
with more relaxed definitions of conservation. For the miRanda-generated target gene list for 
PSD-localized cocaine-regulated miRNAs, we filtered the list to include only those target genes 
with supporting experimental data indicating dendritic or synaptic localization; data compiled 
from six studies138-143 yielded a list of 1,041 target genes (Table 2.S2). 
Functional analysis of target genes 
 We used the Database for Annotation, Visualization, and Integrated Discovery (DAVID; 
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david.abcc.ncifcrf.gov) to interrogate multiple databases in parallel with a list of target genes28. 
We used the GoCharts module to analyze a subset of the target mRNAs identified from 
miRanda analysis. GoCharts uses the classifications of the Gene Ontology Consortium (GO; 
www.geneontology.org), which assigns functional terms to annotated genes and proteins. 
Only those GO terms identified by DAVID with enrichment P < 0.05 were included in Fig. 2.8. 
Quantitative polymerase chain reaction (qPCR) 
 The cDNAs from tissue lysate total RNA were prepared using iScript (BioRad) with 
random primers; a 5 min 65°C step was added to the iScript protocol before chilling and 
adding the enzyme. Pairwise statistical comparisons used the t-test for two samples assuming 
unequal variance and the two-tailed value are reported. Real-time PCR for mRNAs was 
performed using an Eppendorf Realplex2 machine and Sybr-Green (BioRad), with the 
following parameters: 95°C 2 min; 95°C 15 sec, 55°C 15 sec, 68°C 40 sec; repeat 40x. Maximal 
rates of amplification per cycle were calculated for all primer pairs and all samples in all assays 
and averaged 2.03 ± 0.06 (SD) in 6 runs of 96-well plates. Data are calculated with respect to 
GAPDH for each sample within an assay, and data across assays were then averaged because 
the values with respect to GAPDH for each transcript were very consistent. Primer pairs were 
chosen to keep the melt temperature (Tm) between 60 and 62°C (calculated using 
www.basic.northwestern.edu/biotools/oligocalc.html) and products in the 120 ± 5 nt size 
range. Differences between saline and cocaine samples were evaluated using the 2-tailed 
Student's t-test with unequal variances. 
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Primers used for mRNA qPCR 
Primer name Sequence Tm (°C) 
Product 
length (nt) 
Gapdh-for  5’	   TTGTCAGCAATGCATCCTGCACCACC	   3’ 61 
119 
Gapdh-rev  5’	   CTGAGTGGCAGTGATGGCATGGAC	   3’ 61 
Ago2-for 5’	  GACTATCAGCCAGGAATCACGTTCATCG	  3’ 61 
121 
Ago2-rev 5’	   CCACGGTTGTGCCTGCGGGAATG	   3’ 62 
Table 2.2 Primers used for mRNA qPCR 
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MicroRNA qPCR 
 Reverse transcription using mature miRNA-specific primers was performed on 1-10 ng 
total RNA from tissue lysates per the manufacturer’s instructions for the TaqMan MicroRNA 
Reverse Transcription Kit (Applied Biosystems) using the suggested parameters (ice 5 min; 
16°C 30 min; 42°C 30 min; 85°C 5 min). Quantification was performed using the TaqMan 
MicroRNA Assay (Applied Biosystems) with the manufacturer’s recommended amplification 
parameters (95°C 10 min; 95°C 15 sec, 60°C 60 sec; repeat 40x). NAc lysate qPCR was 
performed on RNA isolated from individual animals while striatal-PSD qPCR was carried out on 
the pooled preparations. Data are calculated with respect to an empirically determined 
endogenous control miRNA; total NAc lysate and striatal-PSD miRNA levels were calculated 
with respect to miR-9 and miR-101a, respectively. Normalization data are shown in Fig. 2.13, 
and qPCR data for Fig. 2.3B and 2.5B are in Fig. 2.14. 
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Figure 2.13 Use of miR-101b for normalization and assessment of brain-enriched and 
synaptically-important miRNAs 
(A) Expression of miR-101b from NAc tissue lysates from wildtype adult male mice treated with saline 
and cocaine was evaluated by RNA-Seq (left) and by qPCR (right). RNA-Seq data for miR-101b are shown 
as reads (adjusted, equal total reads/sample) on log10 scale; qPCR data for miR-101b are normalized to 
miR-9 on linear scale. (B) Expression of miR-101a and miR-101b in striatal PSDs from saline- and cocaine-
treated wildtype mice was also evaluated by RNA-Seq (left) and qPCR (right). RNA-Seq data are shown 
as reads (adjusted, equal total reads/sample) on log10 scale; qPCR data are shown as the ratio of miR-
101b/miR-101a expression. Expression of brain-enriched and/or synaptically important miRNAs in NAc 
lysates and striatal PSDs by RNA-Seq (C,E) or qPCR (D,F).  
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Figure 2.14 Validation of RNA-Seq cocaine-induced expression changes by qPCR 
qPCR analysis of cocaine-regulated miRNAs identified in Figures 3 and 4 from NAc lysates (A) and striatal 
PSDs (C). (B) Expression of select PSD-expressed cocaine-regulated miRNAs not appearing in Fig. 4A by 
RNA-Seq. Significance was evaluated using the 2-tailed Student's t-test with unequal (A) or equal (C) 
variance. *P < 0.05; **P < 0.005. 
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Western blot analysis 
 Gels (4-15% Mini-PROTEAN TGX precast gels, BioRad) of subcellular fractions were 
loaded with 1 to 10 µg protein, which was measured using the Bicinchoninic Acid Assay with 
bovine serum albumin as the standard (Pierce, Rockford, IL). Commercially available mouse 
monoclonal antibodies were used: βIII-tubulin (TUJ1; Covance; 1:1000), NR2B (clone N59/20; 
NeuroMab; 1:1000), Ago2 (2E12-1C9; Novus Biologicals; 1:1000), Synaptophysin (SVP-38; 
Sigma; 1:10,000). Commercially available rabbit polyclonal antibodies were also used: 
BiP/GRP78 (Affinity BioReagents; 1:500), DARPP32 (2303; Cell Signaling Technology; 1:1000), 
pan-Trk (MCTrks, SC-414; Santa Cruz Biotechnology; 1:250), E-cadherin (ab53033; Abcam; 
1:1000) and Metadherin (Ab2989; Millipore; 1:500). Rabbit polyclonal antibody JH1159 
(1:250)167 to the C-terminal 13 residues (amino acids 626-638) of rat PC2 was affinity-purified 
using the antigenic peptide linked to AffiGel 15 beads (Bio-Rad Laboratories). 
 For quantitative analysis of purified PSDs from Saline and Cocaine treated mice, three 
different amounts of sample were analyzed to verify the linearity of the response. After 
transfer to polyvinylidene difluoride membranes (Millipore), blots were stained with 
Coomassie Brilliant Blue R-250 and cut to separate the proteins of interest. Blots were 
incubated in primary antibody overnight at 4°C, washed and incubated for 1h at room 
temperature in the appropriate horseradish peroxidase-conjugated secondary antibody 
(Pierce). Washed blots were incubated in Super Signal West Pico chemiluminescence substrate 
(Pierce) for 5min and multiple exposures were collected using a Syngene imaging system 
(Syngene, Frederick, MD). Signals were quantified using GeneTools software; for each dilution 
of each PSD sample, the signal for each protein was normalized to βIII-tubulin and the 
cocaine-to-saline ratio was determined. 
56 
 
Statistical analyses 
 Data across qPCR assays were averaged because the values with respect to the 
endogenous control for each miRNA were very consistent. Outliers were determined with the 
GraphPad Grubbs’ test outlier calculator (graphpad.com/quickcalcs/Grubbs1.cfm). Differences 
between saline and cocaine samples were evaluated using the 2-tailed Student's t-test with 
unequal variances (NAc lysates) or equal variance (striatal-PSDs). For PSD Western blot 
quantification, cocaine-to-saline ratios for the three amounts of each sample were averaged 
and differences were evaluated using the 2-tailed Student's t-test with equal variance. 
Pearson’s Coefficient represents the linear correlation coefficient between 2 samples, X and Y. 
Pearson’s r = covariance(X,Y)/σXσy; σ, standard deviation. 
Online Supporting Material 
Supplementary tables are available online at: 
    http://intron.ccam.uchc.edu/data/pipeline/jodi/THESIS_supplementary_files/CHAPTER_2 
These materials are also available at the journal of publication: 
    http://rnajournal.cshlp.org/content/17/8/1529/suppl/DC1
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CHAPTER 3  
Effects of Cocaine and Withdrawal on the Mouse Nucleus 
Accumbens Transcriptome 
 
The following is a duplicate version of a published manuscript: 
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Graveley B.R., Mains, R.E. Genes Brain Behav 12, 21-33 (2013). 
 
Abstract 
 Genetic association studies, pharmacological investigations, and analysis of mice 
lacking individual genes have made it clear that cocaine administration and withdrawal have a 
profound impact on multiple neurotransmitter systems. The GABAergic medium spiny 
neurons of the nucleus accumbens (NAc) exhibit changes in the expression of genes encoding 
receptors for glutamate and in the signaling pathways triggered by dopamine binding to G-
protein coupled dopamine receptors. Deep sequence analysis provides a sensitive, 
quantitative and global analysis of the effects of cocaine on the NAc transcriptome. RNA 
prepared from the NAc of adult male mice receiving daily injections of saline or cocaine, or 
cocaine followed by a period of withdrawal, was used for high-throughput sequence analysis. 
Changes were validated by qPCR or Western blot. Based on pathway analysis, a 
preponderance of the genes affected by cocaine and withdrawal were involved in the 
cadherin, heterotrimeric G-protein, and Wnt signaling pathways. Distinct subsets of cadherins 
and protocadherins exhibited a sustained increase or decrease in expression. Sustained down-
regulation of several heterotrimeric G-protein β- and γ-subunits was observed. In addition to 
altered expression of receptors for small molecule neurotransmitters, neuropeptides and 
endocannabinoids, changes in the expression of plasma membrane transporters and vesicular 
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neurotransmitter transporters were also observed. The effects of chronic cocaine and 
withdrawal on the expression of genes essential to cholinergic, glutamatergic, GABAergic, 
peptidergic, and endocannabinoid signaling are as profound as their effects on dopaminergic 
transmission. Simultaneous targeting of multiple withdrawal-specific changes in gene 
expression may facilitate development of new therapeutic approaches that are better able to 
prevent relapse. 
Introduction 
 Chronic drug exposure induces persistent changes in the brain that underlie the 
addiction-associated behavioral abnormalities seen in human addicts and rodent models of 
addiction. Data from broad expression studies using microarray technology and from single-
gene approaches suggest that cocaine exposure elicits widespread modifications to the 
transcriptional landscape, including drug-induced changes in epigenetics, RNA processing, 
microRNAs, and gene transcription168,169. These alterations are believed to be integral to the 
neural plasticity seen in addiction. 
 Dopaminergic, glutamatergic, and peptidergic signaling in the mesolimbic system are 
altered in response to cocaine. Repeated exposure to cocaine leads to sensitization, the 
progressive and persistent amplification of behavioral and motivational responses to a fixed 
dose of the same drug95. Sensitization may persist for weeks to years after cessation of drug 
taking, presumably contributing to a reformed addict’s risk for relapse170, which occurs in up to 
ninety percent of addicted individuals171,172. 
 A majority of current research focuses on the effects of cocaine on the mesolimbic 
dopaminergic system, identified in prior studies as the reward center of the brain83. 
Dopaminergic projections from the ventral tegmental area as well as glutamatergic 
projections from the prefrontal cortex synapse on inhibitory GABAergic medium spiny 
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neurons in the ventral striatum (nucleus accumbens; NAc)87. This convergence of 
dopaminergic and glutamatergic projections, as well as accompanying biochemical and 
morphological changes, identified the NAc as a key integration point in the rewarding and 
addictive effects of drugs of abuse86,95,170,171. 
 High-throughput sequencing has a low background signal, facilitates identification 
and absolute quantification of low-abundance and novel transcripts3,5,6,8,9,169,173. We used next-
generation sequencing of mRNAs purified from the NAc to obtain a more complete picture of 
the molecular response to chronic cocaine exposure and withdrawal. Bioinformatic analysis of 
cocaine-regulated transcripts revealed substantial involvement of the Wnt/cadherin and 
heterotrimeric G-protein signaling pathways. Evaluation of the synthetic enzymes, 
transporters, and receptors involved in catecholaminergic, glutamatergic, GABAergic, 
cholinergic, and lipid signaling identified complex responses unique to cocaine and 
withdrawal. 
Results   
Genome coverage 
 To characterize the effects of chronic cocaine and withdrawal on mRNA expression in 
the NAc, we prepared mRNA-Seq libraries from RNA pooled from mice subjected to daily 
saline injections (Saline), daily cocaine injections (Cocaine) or daily cocaine injections followed 
by a week with no injections (Withdrawal). Paired-end sequencing yielded approximately 20 
million uniquely mapped reads for each library (Table 3.1A). The current annotation of the 
Mus musculus genome (2007, mm9) spans ~1.6 billion bases; 3.2% of the genome encodes 
mature mRNAs and 40.6% encodes primary transcripts. We detected 5-6% of the genome in 
the poly(A)+ RNA-Seq data from each NAc library. Approximately 80% of the reads in each 
library mapped to annotated exons; 15-16% of reads mapped to introns and 5% of reads 
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aligned to intergenic regions (Table 3.1B). Mitochondrial reads accounted for roughly 2% of all 
mapped sequences in these libraries (Fig. 3.1). Scatter plots of mitochondrial (Fig. 3.2) and 
ribosomal (Fig. 3.3) gene expression demonstrated no evidence for cocaine-regulation, so 
subsequent analyses were performed on a filtered gene list that excluded both ribosomal and 
mitochondrial genes. 
  
  
61 
 
A. High-throughput sequencing alignment information 
Sample Treatment Number aligning reads Total genome coverage 
 Saline 26,563,428 3.8% 
NAc lysate Cocaine 24,696,981 3.8% 
 Withdrawal 19,767,382 3.1% 
 
B. Read mapping 
Sample Treatment Exonic Intronic Intergenic 
 Saline 79.4% 13.5% 3.1% 
NAc lysate Cocaine 79.0% 16.1% 4.9% 
 Withdrawal 79.0% 16.2% 4.8% 
 
Table 3.1  Read mapping and base coverage for RNA-Seq data 
Sequences from NAc libraries were aligned to the Mus musculus reference genome (2007, mm9; NCBI 
Build 37) using Bowtie24 and allowing up to 2-mismatches. (A) Aligning read numbers and percent 
coverage of the genome. (B) Reads were characterized as aligning to exonic, intronic, or intergenic 
regions based on the existing annotation. 
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Figure 3.1  Contribution of reads mapping to mitochondrial chromosome 
The proportion of mapped sequence reads from NAc lysate libraries aligning to the mitochondrial 
chromosome was determined. Abbreviations: Sal, Saline; Coc, Cocaine; W/D, Withdrawal; chrM, 
mitochondrial chromosome. 
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Figure 3.2  High-throughput sequence analysis of mitochondrial NAc mRNAs 
Pairwise scatter plots of mRNA expression data for NAc lysate (A-C) libraries (Saline, Cocaine, and 
Withdrawal) prepared from adult mouse; shown as log10(RPKM) per sample. Scatter plots include only 
mitochondrial genes (from GO:0005840). R2 values were calculated by least squares best fit. 
Abbreviation: RPKM, reads per kilobase gene model per million mapped reads5. 
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Figure 3.3  High-throughput sequence analysis of ribosomal NAc mRNAs 
Pairwise scatter plots of mRNA expression data for NAc lysate (A-C) libraries (Saline, Cocaine, and 
Withdrawal) prepared from adult mouse; shown as log10(RPKM) per sample. Scatter plots only include 
ribosomal genes (from GO:0005739). R2 values were calculated by least squares best fit. Abbreviation: 
RPKM, reads per kilobase gene model per million mapped reads5. 
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Genome-wide assessment of the effect of cocaine on gene expression 
 Gene expression over a broad (106) dynamic range was evaluated in each library. 
Expression was quantified in reads per kilobase of exon per million mapped sequence reads 
(RPKM), a normalized measure of exonic read density5. For the three NAc libraries, pairwise 
scatter plots revealed similarly varied expression between the Saline/Cocaine, 
Saline/Withdrawal and Cocaine/Withdrawal libraries (Fig. 3.4A-C). The variability of gene 
expression between samples was highest for genes expressed at lower levels. For this reason, 
a lower limit of expression was applied before examining regulation. Since biogenic amine 
transporter (Slc6a2, NET; Slc6a3, DAT; Slc6a4, SERT) transcripts are not expressed in the NAc 
(http://mouse.brain-map.org/), we used their RPKM values to set this lower limit; for inclusion 
in subsequent analyses, a gene had to have an RPKM of > 1.0 in at least one of the three 
treatment groups. We used qPCR to validate the RNA-Seq data (Fig. 3.4D,E). The RNA-Seq and 
qPCR expression levels of 47 transcripts from five neurotransmitter systems from the Saline 
sample showed strong agreement across the two methods (Pearson’s r = 0.75) over a greater 
than 1000-fold range of expression (Fig. 3.4D). A comparison of the ratios of Cocaine/Saline 
measured by RNA-Seq and qPCR was also carried out (Fig. 3.4E). Cocaine-mediated changes in 
gene expression estimated from the RNA-Seq data were consistently larger than the changes 
observed with qPCR; nevertheless, the ratios show good qualitative agreement (Pearson’s r = 
0.60). Differences presumably reflect the much larger dynamic range of RNA-Seq and 
quantification across entire transcripts rather than between single primer pairs.   
Regulation of NAc transcript levels by cocaine and withdrawal 
To evaluate enrichment and depletion of transcripts in NAc lysates prepared from 
mice in the Saline, Cocaine, and Withdrawal groups, we calculated the relative abundance of  
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Figure 3.4  High-throughput sequence analysis of NAc mRNA 
(A-C) Pairwise scatter plots of mRNA expression data for NAc libraries; shown as log10(RPKM) per sample. 
Ribosomal and mitochondrial genes are not included in the scatter plots. R2 values were calculated by 
least squares best fit. Abbreviations: Sal, Saline; Coc, Cocaine; W/D, Withdrawal; RPKM, reads per 
kilobase gene model per million mapped reads5. (D) RPKM data for 47 transcripts in the Saline library are 
compared to qPCR data (normalized to Glyceraldehyde 3-phosphate dehydrogenase, GAPDH) for the 
same transcripts; Pearson’s Coefficient represents the linear correlation coefficient, r. (E) Cocaine/Saline 
ratios for the same 47 transcripts were calculated using RPKM data and qPCR data. Pearson’s Coefficient 
represents the linear correlation coefficient, r, between two samples, X and Y. Pearson’s r = 
covariance(X,Y)/σXσY, where σ is the standard deviation. 
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each mRNA in the three treatment groups, computed Z-scores across samples, and 
hierarchically clustered genes for visualization in a heat map. Of the 19,890 detected genes, 
13,184 were expressed in at least one library at an RPKM > 1.0 and were used in downstream 
analyses. Several patterns of expression emerged from hierarchical clustering, including 
transcripts showing (i) sustained increases in both Cocaine and Withdrawal, (ii) increases only 
in Withdrawal, (iii) transient increases only in Cocaine, (iv) transient decreases only in Cocaine, 
and (v) sustained decreases in Cocaine and Withdrawal (Fig. 3.5A). The full gene list for each 
cluster is available in Table 3.S2. 
Since transcripts exhibiting a sustained change in response to cocaine are included in 
Clusters i (sustained increase), ii (increase, Withdrawal), and v (sustained decrease), we used 
Panther Pathway (Table 3.2A and Table 3.S3) analysis to identify common pathways. Three 
pathways were enriched (P < 0.005) in these three Clusters: cadherin signaling, heterotrimeric 
G-protein signaling (Gαi and Gαs-mediated), and Wnt signaling; since there was a great deal of 
overlap in the cadherin and Wnt signaling pathways, they are discussed together. Other 
pathways were unique to specific clusters (Table 3.S3). For example, components of the 
ionotropic glutamate receptor, metabotropic glutamate receptor group III, and nicotinic 
acetylcholine receptor pathways were enriched only in Cluster i (sustained increase) while 
components of the muscarinic acetylcholine receptor 1 and 3 pathway were enriched in 
Cluster ii (increase, Withdrawal). 
 The pathways exhibiting sustained changes were examined in more detail. Unique 
sets of cadherins and protocadherins appeared in each Cluster (Table 3.3). While many 
cadherins and protocadherins showed a sustained increase in expression (Cluster i), others 
increased only in Withdrawal (Cluster ii) or showed a transient response to Cocaine (Clusters iii 
and iv). The clustered families of protocadherins, Pcdhα, -β, and γ, are important in neuronal  
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Figure 3.5  Differential regulation of clusters of genes in the NAc following cocaine and 
withdrawal 
(A) Normalized mRNA frequency as a function of total reads for NAc lysate libraries (Saline, Cocaine, 
Withdrawal) was calculated for all genes in which one sample had an RPKM ≥ 1.0 (n = 13,184). 
Hierarchical gene expression clustering using Gene Cluster 3.0 and Java TreeView generated the 
dendrogram and heat map. Z-score was computed on normalized mRNA frequency across all samples. 
Blue, low expression; yellow, high expression; grey, no expression. Gene lists from the indicated Clusters 
(i-v) were used in subsequent protein class and pathway analyses. (B) The effects of Cocaine on one of 
the protocadherins identified as a target were verified. Subcellular fractionation of striatal tissue 
revealed enrichment of PCDH10 at the PSD. PSDs purified from the striata of Saline and Cocaine treated 
mice were analyzed for PCDH10; after normalization to bIII tubulin, the Coc/Sal ratio for PCDH10 rose 
24% (P < 0.01; t-test). 
  
 
Table 3.2  Panther Pathways from Cocaine- and Withdrawal-regulated genes in the NAc 
Gene lists from Clusters i-v (Fig. 3.5A) were used in Panther Pathway and Protein Class analysis (http://www.pantherdb.org); pathways 
enriched (P < 0.005) in all three lists relative to the Mus musculus reference genome are indicated. Complete pathway lists are provided in 
Table 3.S3. Abbreviations: Coc, Cocaine; W/D, Withdrawal. 
 
  
PANTHER Pathway 
Mus 
musculus 
genes 
(26,185) 
(i) Sustained 
Increase, Coc & 
W/D (1,387) 
(i) P-
value 
(ii) Increase, 
W/D only 
(1,001) 
(ii) P-
value 
(v) Sustained 
Decrease, Coc 
& W/D (2,670) 
(v) P-
value 
Cadherin signaling 167 19 1.94E-03 16 9.25E-04 30 2.70E-03 
Heterotrimeric G-protein 
signaling – Gαi & Gαs 
169 19 2.21E-03 18 1.32E-04 32 8.89E-04 
Wnt signaling 348 46 3.67E-08 27 5.77E-04 64 9.02E-06 
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development and are synaptically enriched in mature myelinated neurons174. The Pcdhb gene 
cluster includes 22 genes; three showed a sustained increase (Cluster i), five were increased 
only after Withdrawal (Cluster ii), five exhibited an increase only after Cocaine (Cluster iii), and 
one showed a sustained decrease in expression (Cluster v). In contrast, the Pcdhg cluster of 23 
genes exhibited a more homogeneous expression pattern in which expression of all 21 
detected isoforms showed a sustained decrease (Cluster v).  
 We used an antibody to protocadherin 10 (PCDH10), which is known to play a role in 
the development of striatal axons and thalamocortical projections175, to evaluate its 
subcellular localization and quantify its levels in postsynaptic densities (PSDs) purified from 
the striata of saline- and cocaine-treated mice. PCDH10 was enriched in PSD preparations (Fig. 
3.5B); furthermore, PSDs purified from striatal extracts of cocaine-treated mice contained 
more PCDH10 than striatal PSDs from saline controls. A role for extracellular matrix proteins, 
including cadherins and protocadherins, is consistent with previous studies of cocaine-
regulated gene expression in mice169 and postmortem human brain112,176. 
Consistent with the literature, heterotrimeric G-protein signaling (Gαi and Gαs-
mediated) was identified as a major pathway targeted by cocaine. In addition to G-protein 
coupled receptors (GPCRs) for the major neurotransmitters (discussed below), neuropeptide 
(opioid, galanin, somatostatin), lipid, and cadherin-type GPCRs showed cocaine-related 
changes in expression (Table 3.3). 
Panther Pathway analysis identified cocaine-regulated changes in the repertoire of 
intracellular signaling proteins downstream of the regulated Gαi and Gαs-coupled GPCRs 
(Table 3.3 and Fig. 3.6). The diagram in Fig. 3.6 depicts the complex interplay of intracellular 
signaling proteins. For example, only two members of the Mus arrestin gene family are 
expressed outside of the retina177; Arrb1 showed a sustained increase in expression (Cluster i) 
  
Figure 3.6  G i and G s heterotrimeric G-protein signaling schematic.  
Model based on Panther Pathway diagram (http://www.pantherdb.org). Venn diagram depicts color key for signaling components. Genes labeled yellow 
showed a sustained increase in Coc and W/D (cluster i), red genes increased in W/D only (cluster ii), and blue genes had decreased expression in both Coc 
and W/D (cluster v); overlap colors indicate contribution of > 1 cluster to signaling group. For example, GPCRs, which appear  in all three clusters, are shown 
in magenta. Genes from Clusters i, ii, and v were used for this analysis. Abbreviations: Coc, Cocaine; W/D, Withdrawal. 
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 Table 3.3  Clustered genes from the Cadherin/Wnt and Heterotrimeric G-Protein Signaling Pathways 
The cadherin and protocadherin genes appearing in Clusters i-v are identified. Genes in the heterotrimeric G-protein signaling pathway (Gαi and Gαs) that 
fell into Clusters i-v are grouped by function; GPCRs for dopamine, GABA, glutamate and acetylcholine are discussed separately and GPCRs without known 
ligands are not listed. Intracellular signaling proteins are grouped by function. Abbreviations: Coc, Cocaine; W/D, Withdrawal.   
 
(i) Sustained Increase, 
Coc & W/D (ii) Increase, W/D only 
(iii) Transient Increase, 
Coc only 
(iv) Transient Decrease, 
Coc only 
(v) Sustained Decrease, 
Coc & W/D 
Cadherin / Wnt Signaling 
Cadherins Cdh4, Cdh5, Cdh6, Cdh8, Cdh11 Cdh7, Cdh19, Cdh22 Cdh24 Cdh13  
Protocadherins Pcdh1, Pcdh10, Pcdh18, Pcdhb13, Pcdhb14, Pcdhb16 
Pcdhb2, Pcdhb6, Pcdhb7, Pcdhb8, 
Pcdhb9 
Pcdh20, Pcdhb5, Pcdhb10, 
Pcdhb11, Pcdhb19, Pcdhb20  
Pcdha4, Pcdhb12, Pcdhga1, 
Pcdhga2, Pcdhga3, Pcdhga4, 
Pcdhga5, Pcdhga6, Pcdhga7, 
Pcdhga8, Pcdhga9, Pcdhga10, 
Pcdhga11, Pcdhga12, Pcdhgb1, 
Pcdhgb2, Pcdhgb4, Pcdhgb5, 
Pcdhgb6, Pcdhgb7, Pcdhgb8, 
Pcdhgc3, Pcdhgc4, Pcdhgc5 
Heterotrimeric G-Protein Signaling (Gαi & Gαs) 
Type of GPCR: 
Neuropeptide binding Fzd5, Fzd8, Hcrtr2, Npffr1, Oprk1, Oprm1, Prlhr, Tacr1 
Fzd6, Fzd7, Mc3r, Oprd1, Pth1r, 
Smo, Trhr2 
Hcrtr1, Npbwr1, Npy2r, Oxtr, Sstr3, 
Tacr3 Fzd9, Gipr, Nmbr, Npy5r Mc4r, Mchr1, Mtnr1a, Sstr2 
Lipid binding  S1pr3  S1pr4 Lpar1 
Cadherin type Celsr2, Celsr3 Celsr1    
Intracellular signaling proteins: 
GPCR kinases    Grk6 Grk1 
Arrestins Arrb1    Arrb2 
Gβ subunits  Gnb4   Gnb1, Gnb1l, Gnb2, Gnb2l1, Gnb5 
Gγ subunits  Gng7 Gng2  Gng3, Gng8, Gng10, Gng11, Gng13 
RGSs Rgs6 Rgs8, Rgs11 Rgs17 Rgs9, Rgs19 Rgs2, Rgs4, Rgs10, Rgs16, Rgs20 
Adenylate cyclases Adcy1, Adcy4, Adcy6, Adcy9 Adcy2, Adcy5 Adcy8   
Phosphorylase b kinases Phka2    Phkg1, Phkg2 
CREBs Creb3l2, Crebbp    Creb3 
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while Arrb2 exhibited a sustained decrease (Cluster v). Transcripts encoding the β- and γ-
subunits of heterotrimeric G-proteins were primarily identified in Cluster v (sustained 
decrease). In contrast, Regulators of G-protein signaling (RGS genes) appeared in all clusters. 
Transcripts encoding four adenylate cyclase genes showed a sustained increase in expression 
(Cluster i) while the transcripts encoding two additional adenylate cyclase genes 
demonstrated increased expression only in the Withdrawal group (Cluster ii). 
Panther Protein Class analysis (Table 3.S4) identified Cytoskeletal Proteins, 
Transcription Factors, and Transferases as the three Protein Classes enriched in genes 
exhibiting a sustained response (Clusters i, ii, and v; P < 0.0001). Sustained up-regulation of G-
protein modulators and guanyl-nucleotide exchange factors (Cluster i) was also observed. 
Several Protein Classes involved in interactions with Ca2+ (calcium-binding proteins, 
calmodulin and intracellular calcium-sensing proteins) were enriched only in Cluster v 
(sustained down-regulation). GPCRs, ligand-gated ion channels, membrane trafficking 
proteins and neuropeptides were also enriched in Cluster v. 
Widespread effects of cocaine and withdrawal on catecholaminergic, GABAergic, 
cholinergic, glutamatergic, and endocannabinoid pathways 
Dopamine, norepinephrine, and serotonin receptors expressed in the NAc play a 
critical role in addiction. Transcripts encoding the dopamine receptors, Drd1a, Drd2, Drd3, and 
Drd5, exhibited different patterns of response to cocaine and withdrawal (Fig. 3.7). Drd1a was 
known to decrease in response to cocaine treatment, while Drd2 was known to increase178. 
Adra1a, Adra2a and Adrb1 adrenergic receptor expression rose in response to cocaine 
treatment, while expression of Adra1b, Adra2b, and Adra2c fell. Six of the twelve serotonin 
receptors (Htr1b, Htr2a, Htr2c, Htr4, Htr5a, Htr6) exhibited increased expression in response to 
cocaine and/or withdrawal. The long-term changes during withdrawal were verified by qPCR  
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Figure 3.7  Regulation of Receptors for Biogenic Amines 
RPKM data are shown for dopamine, adrenergic and serotonin receptor transcripts (RPKM > 1) in the 
Saline library. Z-scores were calculated as described in Methods. Transcripts included in this group but 
expressed at an RPKM < 1 are listed to the side. Ppp1r1b (DARPP32), a multiply phosphorylated 
phosphatase inhibitor highly expressed in medium spiny neurons, is included for comparison. 
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for Drd1a, Drd2, Adra1a, Adra2b, Htr1d, Htr2a, Htr2c, and Ppp1r1b (DARPP32). 
Over 90% of the neurons in the NAc are GABAergic medium spiny interneurons179; the 
genes involved in synthesizing, storing and retrieving GABA (γ-aminobutyric acid) are 
expressed in the NAc, along with ionotropic and metabotropic GABA receptors (Fig. 3.8). 
Expression of the GABA-synthesizing enzymes (Gad65, Gad67), the vesicular inhibitory amino 
acid transmitter transporter (Viatt) and the plasma membrane transporters (Gat1, Gat3 and 
Gat4) rose in response to cocaine and withdrawal. The three Na+/Cl--dependent GABA 
transporters are expressed by astrocytes and retrieve GABA after secretion180-182; neurons also 
express Gat1183. Levels of Gat4 were highest after Cocaine while levels of Gat1 were highest in 
Withdrawal. Multiple GABAA receptor subunits are expressed at similar levels; while some 
showed a sustained increase in expression (Gabrb2, Gabrb3, Gabrg3, Gabrq), Gabrb1 expression 
decreased in Withdrawal and Gabrd expression decreased after Cocaine but recovered in 
Withdrawal. Expression of GABAB receptor subunits (Gabbr1, Gabbr2) increased after Cocaine 
and increased further during Withdrawal. 
Glutamatergic signaling plays an essential role in drug abuse, with major 
glutamatergic inputs onto NAc medium spiny neurons (MSNs) coming from amygdala, 
hippocampus, and prefrontal cortex184,185. The effects of cocaine on expression of ionotropic 
and metabotropic glutamate receptors have been studied in detail171,184,186 and were largely 
confirmed in our analysis (Fig. 3.9). Glutamatergic inputs acutely excite NAc MSNs primarily via 
activation of AMPA receptors, a step considered necessary for initiation of drug seeking 
behavior187. AMPA receptor expression showed only small changes during Cocaine 
administration; Gria1 increased substantially while Gria3 decreased during Withdrawal 
(confirmed by qPCR). Expression of several NMDA receptor subunits increased during Cocaine 
administration (Grin1, Grin2a, Grin2b, Grin2d, Grin3a) (several confirmed by qPCR). Expression 
of kainate receptors Grik1, Grik2, and Grik3 showed a sustained increase while expression of  
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Figure 3.8  Regulation of Genes Affecting GABAergic Transmission 
Data were analyzed as described for Fig. 3.7. The transcripts encoding glutamic acid decarboxylase 65 
and 67 (Gad1 and Gad2) are expressed at similar levels. GABA transport into synaptic vesicles requires 
Slc36a1; retrieval of GABA from extracellular space requires Slc6a1, Slc6a13, or Slca11. Multiple 
ionotropic GABAA receptor subunits are expressed in the NAc; expression of metabotropic GABAB 
receptor Gabbr1 greatly exceeds expression of Gabbr2. 
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Figure 3.9  Regulation of Genes Affecting Glutamatergic Transmission 
Data were analyzed as described for Fig. 3.7. Expression of all three vesicular glutamate transporters 
(Vglut) and four of the plasma membrane glutamate transporters (Slc1a1, Slc1a2, Slc1a3, Slc1a6) was 
above the cutoff level. Multiple subunits of the ionotropic glutamate receptors (AMPA, NMDA, and 
Kainate) and multiple metabotropic glutamate receptors are expressed at similar levels. 
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Grik4 and Grik5 showed a sustained decrease. Expression of the five most-highly expressed 
metabotropic receptors for glutamate (Grm1, Grm3, Grm4, Grm5, and Grm7) showed a 
sustained increase. Vesicular glutamate transporters (Vglut) can be expressed in GABAergic 
and cholinergic neurons as well as in glial cells188. Transcripts encoding all three Vgluts were 
detectable in the NAc, which contains no primarily glutamatergic neurons; expression of 
Vglut1 mRNA exceeded that of Vglut2. Na+-dependent plasma membrane glutamate 
transporters (Eaat1 through Eaat5), which remove glutamate from the synaptic cleft and 
perisynaptic area, also play a critical role in glutamatergic transmission. Three of the four Eaats 
expressed in the NAc (Eaat1, Eaat2, and Eaat3) exhibited a sustained increase in expression 
while Eaat4 exhibited reduced expression in Withdrawal. Eaat1 and Eaat2 are primarily 
expressed in glia, while Eaat3, Eaat4 and Eaat5 show widespread neuronal expression 
throughout the brain189. 
A small population of giant aspiny cholinergic interneurons is found in the NAc190; 
expression of both the plasma membrane choline transporter (Cht1), which provides the rate-
limiting substrate, and choline acetyltransferase (ChAT) was increased by Cocaine and further 
increased by Withdrawal (Fig. 3.10). Expression of each of the major nicotinic ACh receptor 
subunits found in the NAc (Chrna4, Chrna7, and Chrnb2) and three muscarinic ACh receptors 
(Chrm2, Chrm3, and Chrm5) showed sustained increases, many verified by qPCR.  
The endocannabinoid system is heavily involved in many reward-seeking responses to 
drugs of abuse191. Levels of transcripts encoding Cnr1 (the CB1 endocannabinoid receptor) and 
the cannabinoid synthetic enzymes Dagla and Napepld showed sustained increases in Cocaine 
and Withdrawal, while Daglb showed a sustained decrease (Fig. 3.11). The effect of Cocaine 
expression on each of these genes was confirmed by qPCR analysis of two separate sets of 
animals.  
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Figure 3.10  Regulation of Genes Affecting Cholinergic Transmission 
Data were analyzed as described for Fig. 3.7. Although only a small percentage of the neurons in the 
NAc are cholinergic, choline acetyltransferase (ChAT), high affinity plasma membrane choline 
transporter (Slc5a7) and vesicular acetylcholine transporter (Slc18a3) transcript levels all fall above the 1 
RPKM cutoff. Only three of the many nicotinic acetylcholine receptor subunits are expressed in the NAc 
while all five muscarinic receptors are expressed. Expression of each of the genes involved in cholinergic 
transmission is elevated in withdrawal. 
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Figure 3.11  Regulation of Genes Affecting Endocannabinoid Signaling 
RPKM data were analyzed as described for Fig. 3.7. While transcripts encoding the two 
enzymes that synthesize the endocannabinoid 2-arachidonoylglycerol (diacylglycerol lipase α 
and β; Dagla and Daglb) are expressed at similar levels in the NAc, they respond to cocaine in 
an opposite manner. Expression of transcripts encoding cannabinoid receptor 1 (Cnr1) greatly 
exceeds that of cannabinoid receptor 2 (Cnr2) and is responsive to cocaine. 
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Discussion 
Single-gene, proteomic, and microarray analyses demonstrated that cocaine produces 
widespread, multi-faceted responses in the NAc168,169. Next-generation sequencing identified 
pathways not previously thought to play any role in addiction and facilitated systematic 
cataloging of changes in all components of known signaling pathways. With greater 
sequencing depth, changes in editing, splicing, imprinting and allele-specific expression can 
be quantified3,5,6,8,9,169,173. Components of the Wnt, cadherin, and heterotrimeric G-protein 
signaling pathways were over-represented among cocaine-responsive transcripts; cross-talk 
between these signaling cascades is extensive192. 
Global comparisons of gene expression identify signaling pathways targeted by 
cocaine 
Cadherin/Wnt pathways 
By sequencing PSD-localized, cocaine-regulated striatal microRNAs, we previously 
identified miR-8 family members as key players in the response to cocaine169. Although the 
miR-8 family has primarily been studied for its role in cancer progression and metastasis, we 
verified cocaine regulation of two bioinformatically-predicted cadherin family targets169. We 
identified over forty cocaine-regulated cadherin and protocadherin transcripts; genes from 
the Pcdhβ cluster were primarily up-regulated following cocaine in both a transient and 
sustained fashion (Clusters i-iii), whereas genes from the Pcdhγ cluster were exclusively found 
to undergo a sustained down-regulation following cocaine exposure (Cluster v). 
 A few studies have suggested a role for cell adhesion and extracellular matrix proteins 
in the response to cocaine. Disturbances in cortical cytoarchitecture in animal models of 
prenatal cocaine exposure resembled changes observed when Wnt/cadherin pathway 
function was altered; this lead to the prediction that these pathways play a role in the 
82 
 
response to cocaine193. As observed here (Cluster i), Cdh6 and Cdh11 expression increased in 
the frontal cortex of E18 pups taken from dams treated with cocaine for 10 days193. Also 
contributing to alterations in the extracellular milieu is cocaine-mediated down-regulation of 
glycosyltransferase expression; these enzymes are crucial for the synthesis of cell surface 
glycoproteins. In a compilation documenting changes in gene expression in postmortem 
tissue from cocaine addicts, cell adhesion molecules were identified as major targets109,112. 
Heterotrimeric G-protein pathways 
Transcripts encoding GPCRs, heterotrimeric G-protein subunits, regulators of G-
protein signaling (RGS), GPCR kinases (GRK) and adenylate cyclases (Adcy) responded 
differently to cocaine and withdrawal. Genes encoding GPCRs and RGSs were identified in all 
five clusters. Particularly striking was the prevalence of GPCRs for neuropeptides, with 
different receptor subtypes in different clusters (e.g., Wnt, galanin, somatostatin, and opioid 
receptors). The µ-opioid (Oprm1) receptor, associated with increased sensations of reward and 
pleasure, showed a sustained increase in expression in response to cocaine, as expected104,172, 
as did the endocannabinoid (Cnr1) receptor194,195. The δ-opioid receptor (Oprd1), also involved 
in positive reinforcement of drugs of abuse196, increased expression only in Withdrawal. The κ-
opioid receptor (Oprk1), crucial to the negative emotional state of withdrawal172, showed a 
sustained increase, as also observed in postmortem tissue from cocaine overdose victims197. 
Transcripts encoding several neuropeptides were substantially down-regulated by cocaine: 
Pomc (proopiomelanocortin), Tac1 (tachykinin), Oxt (oxytocin) and Cartpt (CART; cocaine and 
amphetamine regulated peptide). 
Consistent with a major role for cadherins in the response to cocaine, seven 
transmembrane cadherins (Celsr) were identified in clusters i and ii. Genes encoding adenylate 
cyclases appeared in Clusters i, ii, and iii. On the other hand, the majority of genes encoding 
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the β- and γ-subunits of the heterotrimeric G-proteins fell into cluster v (sustained decrease). 
The few genes whose expression is uniquely regulated in Withdrawal are of special interest; 
these transcripts may provide insight into the biochemical and cell biological alterations 
underlying reinstatement of drug-seeking behavior, ultimately helping identify potential 
therapeutic approaches to prevent relapse185. 
Neurotransmitter-specific effects  
Expression of the D3 dopamine receptor (Drd3) increased in response to Cocaine and 
remained elevated after Withdrawal (cluster i); in contrast, D2 dopamine receptor (Drd2) 
expression increased only after Withdrawal. An increase in D3 receptor expression was 
observed in the NAc of cocaine overdose victims197 and in rats 45 days after cocaine self-
administration ceased157. Recent work suggests that dopamine receptor dysregulation, 
mediated by decreased D2 and increased D3 receptor expression, contributes to increased 
cocaine-seeking behavior after prolonged withdrawal157. Alterations in serotonin signaling are 
also recognized as important in drug addiction198, and we observed cocaine-responsive 
changes in gene expression across many of the serotonin receptors. 
Expression of many of the genes responsible for GABA synthesis, transport into 
synaptic vesicles, and retrieval from the synaptic cleft rose following cocaine treatment and 
increased further during withdrawal. Daily cocaine injections decreased GABAA receptor-
mediated maximal evoked currents and miniature inhibitory postsynaptic currents on 
dopamine neurons in the VTA199; furthermore, GABAA receptor function has been implicated in 
dopamine-mediated alcohol reward200. GABAB receptor agonists attenuated cocaine 
reinforcement and reduced cocaine craving in a study of human cocaine users201; while the 
precise mechanism of these behavioral effects is unknown, activation of GABAB receptors in 
the NAc reduces dopamine release from dopaminergic projections from the VTA202. Changes 
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in GABAA receptor subunit expression, which fell during withdrawal, and in GABAB receptor 
expression, which rose, could contribute significantly to altered synaptic transmission. 
A growing body of literature has focused on the role of AMPA, NMDA and kainate 
receptor-mediated glutamatergic transmission into the NAc in the development of addiction 
and addictive-like behaviors186. Increased glutamate receptor mRNA expression parallels 
increases in cell surface expression of GluR1-containing AMPA receptors following cocaine 
withdrawal203, along with a specific population of GluR2-lacking calcium-permeable AMPA 
receptors185. We saw sustained up-regulation of Gria1 (GluR1) transcripts, a transient increase 
in Gria4 (GluR4) transcripts, and no change in Gria2 (GluR2) transcripts. While expression of 
kainate receptor 3 (Grik3) rose substantially, expression of Grik4 and Grik5 fell. NMDA receptors 
are critical for the behavioral response to drugs of abuse204,205; new spines appearing in the 
NAc following cocaine are enriched in NMDA receptors and are not formed if NMDA receptor 
currents are blocked206,207. Correspondingly, transcripts encoding several NMDA receptor 
subunits rose in response to cocaine. Expression of the more prevalent metabotropic 
glutamate receptors also increased. Perhaps the most significant finding is that expression of 
Slc17a7 and Slc17a6 (Vglut1 and Vglut2) exhibited sustained down-regulation after cocaine 
treatment and withdrawal. 
Cholinergic transmission in the NAc contributes to addiction through the modulation 
of dopamine signaling and reward processing208. Increased expression of both choline 
acetyltransferase and the plasma membrane choline transporter in the giant aspiny 
cholinergic interneurons could increase cholinergic signaling at both nicotinic and muscarinic 
ACh receptors expressed on the GABAergic output neurons. 
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Conclusion 
We used next-generation sequencing to generate a comprehensive catalog of 
transcriptional changes that occur in response to cocaine treatment and withdrawal in the 
primary reward center of the brain. Pathway analysis enabled the complete categorization of 
transcriptional changes in signaling pathways known to be important in addiction along with 
the identification of pathways not previously considered important. These data should serve 
as a resource for development of new targets for cocaine therapy and facilitate selection of 
protein interaction and pathway targets for future study.  With more information about their 
normal physiological roles, the extracellular domains of the many cadherins and 
protocadherins that respond to cocaine may be useful therapeutic targets. Pharmaceutical 
cocktails targeted to a subset of the specific GPCRs whose expression is altered during 
withdrawal may prove to be more effective than treatments targeting a single pathway.  
Methods and Materials   
Cocaine Treatment of Mice 
 Adult male C57BL/6 mice (Jackson Laboratories, Bar Harbor, Maine; 2-5 months old) 
were group-housed in the animal facility at the University of Connecticut Health Center on a 
12 h light/dark cycle (lights, 7:00am-7:00pm) and handled in accordance with Institutional 
Animal Care and Use Committee guidelines. After acclimation for one week, animals were 
handled for 1 min/day for 2-3 days prior to injections. On each treatment day, animals were 
allowed to acclimate to the behavior room for 45-60 minutes before beginning injections. 
 Cocaine treatment was performed as described169. Animals were given saline (10 
ml/kg/day) or cocaine (10 or 20 mg/kg/day) intraperitoneally for 7 days and locomotor activity 
was monitored daily using a 15” x 15” Plexiglas chamber (PAS Open Field System, San Diego 
Instruments); after the 7th injection, locomotor activity was three-fold higher in mice receiving 
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cocaine than in mice receiving saline (Fig. 3.12)98,209. Administering 10 mg/kg cocaine on the 
first and last days produces more reliable locomotor sensitization (locomotor ambulations on 
day 7 ÷ day 1), as originally demonstrated in rats166, and was used in later experimental sets in 
this work. Animals were sacrificed by decapitation 24 hours after the final injection with the 
exception of mice in the withdrawal groups, which were kept in the home cage for 8 or 28 
days after the final cocaine dose prior to tissue harvest; elevated locomotor responding was 
maintained for the 28 day withdrawal period (Fig. 3.12). Quantitative polymerase chain 
reaction (qPCR) validation was performed on RNA samples used for library preparation (8 
animals analyzed separately in each treatment group) and on two biological replicate groups 
of mice sensitized in a similar manner98: 8 each saline and cocaine; 4 each saline, cocaine, and 
28 days withdrawal. Pairwise comparisons were performed and subjected to t-test (p<0.05 
taken as significant). 
RNA and Library Preparation and Sequencing 
 NAc punches were taken from individual mice (at least 8 animals/treatment group). 
Total RNA was prepared using TRIzol (Invitrogen)169. Average yield of total RNA per NAc punch 
was 6.3±0.6 mg. Total RNA used for NAc library preparation consisted of equal amounts of 
RNA from 8 individual mice for each treatment. One Saline, one Cocaine, and one 7-day 
Withdrawal mRNA-Seq library was prepared from each pooled RNA sample according to 
manufacturer’s specifications (Illumina). Briefly, total RNA was treated with DNase I; poly(A)+ 
RNA purified using Dynal magnetic beads (Invitrogen) was fragmented by partial alkaline 
hydrolysis (Ambion) and reverse-transcribed using random primers and SuperScript II 
(Invitrogen). cDNA was size-selected (∼200 bp insert) on 2% agarose gels. Libraries were 
prepared for sequencing using the Paired-End DNA Sample Prep Kit (Illumina).  
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Figure 3.12  Cocaine causes long-lasting locomotor sensitization 
(A) Two sets of 8 male mice were subjected to saline or cocaine injection as indicated, and locomotor 
activity for the subsequent 45 min was recorded. RNA from these mice was used for Q-PCR validation. 
(B) Two sets of 8 male mice were subjected to saline or 20 mg/kg cocaine injection for 8 days followed 
by 30 min of locomotor monitoring. A third set of 8 male mice received 20 mg/kg cocaine for 8 days, 
was subjected to withdrawal for 8 days, and then locomotion was monitored in 3 of the 8 mice 
following a test injection of 20 mg/kg cocaine. RNA from these mice was used for RNA-Seq. (C) An 
additional two sets of 4 male mice each were subjected to saline or 20 mg/kg cocaine injection daily for 
7 days, followed by 15 min of locomotor monitoring; a third set of 4 mice received cocaine for 7 days, 
was subjected to withdrawal for 28 days, and then locomotion was monitored after a test injection of 20 
mg/kg cocaine. RNA from these mice was used for Q-PCR validation. Abbreviations: Sal, Saline; Coc, 
Cocaine; W/D, Withdrawal. The number following the abbreviation indicated number of days in a given 
treatment paradigm. 
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NAc libraries were sequenced in nine lanes (3 technical replicates per sample) on an 
Illumina GAIIx using a 37-cycle paired-end sequencing protocol. Replicates were analyzed for 
intra-sample disparity and read data from all three lanes were then merged into one 
composite data file per sample; intra-sample coefficient of determination, R2 ≥ 0.98. The 
composite file was used for subsequent analyses. 
mRNA-Seq Data Analysis 
 Sequences and quality scores were extracted from image files using Firecrest, Bustard, 
and GERALD software. Sequences were aligned to the Mus musculus genome (2007, mm9; 
NCBI Build 37) using Bowtie (http://bowtie-bio.sourceforge.net; version 0.12.7)24 permitting 
multi-alignment and allowing up to 2-mismatches. Ambiguous alignments were resolved 
using the Spliced Paired-end Aligner Perl script210. Robust assembly of novel transcripts and a 
complete analysis of cocaine-induced alternative splicing requires greater transcript coverage 
and read depth than we obtained25. 
 Normalized mRNA expression was calculated as RPKM (reads per kilobase gene model 
per million mapped reads)5 from aligned sequence reads; Z-scores were computed from 
frequency data using the following equation: (x - µ)/σ; x, sample frequency; µ, mean across all 
samples; σ, standard deviation across all samples. Gene expression data (Z-scores) were 
hierarchically clustered using Gene Cluster 3.0 (http://rana.lbl.gov/EisenSoftware.htm); heat 
maps were generated using Java Treeview 
(http://www.sourceforge.net/projects/jtreeview/files). Gene lists were submitted to the 
Panther website (http://www.pantherdb.org) for analysis of Pathway and Protein Class 
enrichment compared to the Mus musculus reference gene list. Western and qPCR analyses 
were performed as described169; primer sequences are in Table 3.5. 
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Table 3.4  Primers used for quantitative PCR 
 
Gene Name  Sequence Tm (°C) 
Length 
(nt) 
GAPDH (G3PDH) NM_008084.2 
TTGTCAGCAATGCATCCTGCACCACC	   61 
119 
CTGAGTGGCAGTGATGGCATGGAC	   61 
glutamate receptor, ionotropic, AMPA4 
CCCAGTATTCTAGAGGGGTGTTTGCC	   61 
123 
CTTCAGTGGGGAAGCTTGGTGTGATG	   61 
glutamate receptor, ionotropic, AMPA3 (alpha 3) 
CACACGACGCAATACTGGTCATAGCAG	   61 
120 
GACTCCAGGGCACAGCAGGATTTG	   61 
glutamate receptor, ionotropic, NMDA2B 
CTGAGACTGAAGAACAGGAAGATGACCATC	   62 
119 
CGGGACTGTATTCCGCATGCAGG	   61 
dopamine receptor D1A 
GCTGGCTTTTGGCCCTTTGGGTC	   61 
123 
GCTGGAGATAGCCCAATACCTGTCC	   61 
dopamine receptor 2 
CCATCTCTTGCCCACTGCTCTTTGG	   61 
122 
GGTGACGATGAAGGGCACGTAGAAC	   61 
glutamate receptor, ionotropic, AMPA1 
GTCAGCGACGGCAAATACGGAGC	   61 
120 GACCAAGGTTATGGTCAAGGGGGC	   61 
CCTCGCTTGTCACGCCCCC	   60 
mNR2A 
CTCTCGTAGCATAAGCCTCAAGGACAG	   61 
123 
CAGACCTTGGGGGAAAAGGGAGCTTTTG	   61 
mDARPP32 
AGACCCACAGGGCAGGTCCTAAG	   61 
126 
GTTGAAGTCTATGAGAGGGTTGGGGAC	   61 
GAD65 
GAGGGTTACTGATGTCCCGGAAACAC	   61 
120 
CCAGGAGAGCTGAACACTGCAAGG	   61 
GAD67 
TCTCCTATGACACCGGGGACAAGG	   61 
129 
GGCATTTGTTGATCTGGTTTTCAAATCCCAC	   60 
GABA-a1  Gabar1 
CCAGTTTCGGACCAGTTTCAGACCAC	   61 
120 
TGTTTAGCCGGAGCACTGTCATGGG	   61 
DGL-alpha 
CTCACGCACAGAGCTGCTGGCA	   60 
120 
ATGGTTGCACTTGGTGGTCGCTCAG	   61 
DGL-beta 
CTGCATGGCTGTTGGTACGGACTG	   61 
120 
GGTTAGAAGTGTCTGCTCTCCAAGAAGA	  	  	  	   60 
NAPE-PLD 
GGATGAGTATGAGGACAGCCAGTCTC	   61 
120 
GGAGAACCTAGAAGACACACTTCCTCC	   61 
Choline acetyltransferase 
GTTATAACCCCCAGCCTGAGGCC	  	  	   61 
120 
GGTCTCTCATGTCAACAAGGCTCGC	  	  	   61 
M1 muscarinic R 
AGGAACAACTGGCCAAGAGAAAGACCTT	   60 
120 
GCACCATGATGTTATATGGTGTCCAGGT	  	  	   60 
B2 Nicotinic R 
TCCCTCGACGTACCGCTGGTG	   60 115 
GCGTGGTAGGCGAACGGTGG	   60 
GABA-B1 
CCGTGGCTTGACTCGCGACC	   60 
117 
AGGCACTTGCGCACCTTGGGC	   60 
EAAT1 glial 
ACCATTAACATGGATGGGACCGCCC	   61 
121 
CGGCCGTGGCTGTGATGCTTATTG	  	  	  	   61 
EAAT2 glial 
CATTAACATGGATGGCACAGCCCTTTAC	   60 
120 
TGCCCAGGTTTCGGTGCTTTGGC	   61 
EAAT3 neuronal 
ACTGTCCTGAGCGGGCTTGCAATC	   61 
117 
TGTCAGGAGAGCCTGCGCCATAC	   61 
EAAT4 neuronal 
GCCTGCAGACCATGACCCGAG	   60 
125 
GAGCTGGTACGGGCGCAAGG	   60 
GABA-B1 
CCGTGGCTTGACTCGCGACC	   60 
117 
AGGCACTTGCGCACCTTGGGC	   60 
GABA transporter 
CAGGGTGGCATTTATGTCTTCAAACTGTTTG	   60 
123 
ATAGAACCGGTTGACACCATAAAACCAGG	  	  	  	   60 
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Gene Name  Sequence Tm (°C) 
Length 
(nt) 
Kainate 5 
TCCTGGTTGTCGTTCCTCGGGC	   60 
117 
AGCCGGCATCTTCCTCCCCTC	   60 
NR1 
AACAAGCGCGGACCCAAGGCAG	   60 
121 
CGCTTGCAGAAAGGATGATGACCCG	   61 
mGluR5 
TGGCTCTGGCCCCGGTGCA	   60 
121 
GAAGCGCTCCTCTGCCTCTGC	  	  	  	  	   60 
5HT-1d 
CGGTGAACCAGCGGTGACCC	   60 
117 
TGGTTCTGTCCTGCTGACGGCTTTG	   61 
5HT-2c 
CGTCGGCGTCGTGGAGATCG	   60 
120 
TCCAGCATCTCCGCGCCAATCG	   60 
vAChT 
TCCTTCGCGCCCTTAGTGGTCTC	  	  	   61 
120 
GCCATAGACTGATACGTGGCGCAC	  	  	   60 
vGlut1 
AGAAGCGGCAGGAAGGCGCG	   60 
120 
TGTAGCGACGAGGGAGGCCAAAG	   61 
vGlut2 
TTGGTGCTTGCAGTAGGATTCAGTGGATT	  	  	   60 
120 
CAGCGTGCCAACGCCATTTGAAATGC	  	  	  	   61 
VIATT 
CGCTGAGGCTACGCGAGGTG	   60 
118 
CCGAAGCCTCTGTGTGGACATGG	   61 
Cnr1; CB1-Receptor 
AAGGCTCACAGCCACGCAGTTCG	   61 
120 
TAATGTCCATGCGGGCTTGGTCAGG	   61 
Adra1a 
TGCATCAACCCTATCATATACCCATGCTC	   60 
120 
AGTGTAGCCCAGGGCATGCTTGG	   61 
Adra2b 
CCACCCTTGCAGCAGCCTCAG	   60 
120 
GCTCAGCTGTGTCCGACGGC	   60 
Htr1b 
GAACCAAGTCAAAGTGCGAGTCTCAGAC	   61 
120 
GCCAACACACAATAAATGCTCCTAAAATGATCC	   61 
Htr2a 
GGACGATGCAGTCCATCAGCAACG	   61 
120 
TGCAGATGACGGCCATGATATTGGTGATG	   61 
Gabbr2 
GAAGATTCGAAGACCTCCACCTCAGTC	   61 
120 
GTCTTTGTCCAGCTCTGTGATCTTCATTC	   60 
Gabrd 
CAGGAAGAAACGGAAAGCCAAGGTCAAG	   61 
120 
GAGATAGCCAACTCCTGACTGACC	   61 
Grik3 
CATCGACTCCAAGGGCTATGGCATC	   61 
120 
CACTTCTCCTTCATGATGTGCAGTTTGTC	   60 
Chrm5 
TGTTCCTTCCCAGTGTCCAAAGACCC	   61 
120 
CAAGGTCTGCGCCGCTTTCCTCT	   61 
Chrna7 
CGCTGCAGCCTGGCCAGTGTGGAGC	   60 
120 
AGTCTGGAGTTGGGGCACAGTGC	   61 
Sesn3 
CGAATGGTCTACAATCTCACCTACAACAC	   60 
120 
CATAGTCATCATACCTGATTCCAAACATACAGTG	   61 
Hipk2 
CAGCAGCGCACAGGGCACAAC	   60 
120 
TTCACTGGCCTGGGTCTTCAGTGG	   61 
Add2 
GACCACGTGGATGAAGGCTGATGAAG	   61 
120 
ATGTCCAGAACTTCCTGGGGGTCAG	   61 
Kcnb1 
AGACTCATGGAGACCAACCCCATCC	   61 
120 
GAAGTTAACCTTGAGCGCTCGCAGC	   61 
Shc3 
ACGGAAGGACCTCTTTGACATGAAGCC	   61 
120 
	   	  GGGGCTCTGGGTGTGACCG	   60 
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Abstract 
 Dendritic spines are the postsynaptic sites for the majority of excitatory synapses in 
the mammalian forebrain. While many spines display great stability, others change shape in a 
matter of seconds to minutes. These rapid alterations in dendritic spine number and size 
require tight control of the actin cytoskeleton, the main structural component of dendritic 
spines. The ability of neurons to alter spine number and size is essential for the expression of 
neuronal plasticity. Within spines, guanine nucleotide exchange factors (GEFs) act as critical 
regulators of the actin cytoskeleton by controlling the activity of Rho-GTPases. In this review 
we focus on the Rho-GEFs expressed in the nucleus accumbens and localized to the 
postsynaptic density, and thus positioned to effect rapid alterations in the structure of 
dendritic spines. We review literature that ties these GEFs to different receptor systems and 
intracellular signaling cascades and discuss the effects these interactions are likely to have on 
synaptic plasticity. 
Introduction 
 In the mammalian forebrain, the vast majority of excitatory synapses (75-90%) 
terminate on dendritic spines211,212. While many of these spines are stable, lasting for months 
even in vivo, one of the key hallmarks of spines is their lability. Dendritic spine size changes in 
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response to a variety of extracellular stimuli. Of particular importance, stimuli that induce 
long-term potentiation, believed to be the cellular correlate of learning, result in increases in 
both spine size and spine density in ex vivo slice preparations213-217. Additionally, animals that 
have undergone training in a fear conditioning paradigm have altered dendritic spine content 
and morphology in the amygdala, the brain region responsible for this type of learning218,219.  
 While alterations in dendritic spine plasticity are important for learning and memory, it 
is likely that they play a role in pathological plasticity as well. Chronic treatment with cocaine 
or amphetamine increases spine density in the nucleus accumbens (NAc), while chronic 
morphine treatment decreases spine density in this crucial region96,99,220-222. In addition to 
addiction, various forms of mental retardation and psychiatric conditions such as 
schizophrenia have been linked to changes in spine morphology223-228. For example, patients 
with fragile X syndrome demonstrate a profound increase in spine density229-232, while a 
number of non-syndromic mental retardations show decreases in spine density233,234. Down’s 
syndrome patients have significantly decreased dendritic spine density, branching and length 
in various cortical subregions223,235. Clearly, tight regulation of spine formation is crucial for 
normal neuronal function.  
 Key to the regulation of dendritic spine formation and function is the actin 
cytoskeleton, which makes up the structural core of the spine216,236-240. Actin dynamics are 
crucial to the plasticity involved in forming and reshaping new spines. Rho-GTPases, a sub-
family of the small GTP-binding proteins, are critical for regulation of the actin cytoskeleton 
and myriad other cellular functions115,216,240-243. We focus here on the signaling pathways used 
to control these molecular switches at the postsynaptic density. 
Control of the Actin Cytoskeleton: Rho Proteins 
 Rho-GTPases function as tightly regulated molecular switches. In their basal state, 
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these proteins are GDP-bound and inactive. Activation is controlled by guanine nucleotide 
exchange factors (GEFs), which catalyze the exchange of GDP for GTP. GTP-bound Rho-
GTPases are active and can form high-affinity interactions with their downstream targets, 
regulating target protein activity and localization244. GTPase activating proteins (GAPs), which 
accelerate the GTPase activity of their target Rho proteins, return the Rho proteins to their 
inactive, GDP-bound state. While there are 61 Rho-GEFs and 68 Rho-GAPs encoded by the 
human genome, there are only 20 Rho-family GTPases245 (http://www.uniprot.org/). The gene 
tallies differ slightly in the mouse, with 58 Rho-GEFs, 56 Rho-GAPs and 20 Rho-GTPases 
(http://www.uniprot.org/). In both species, the excess of GEFs and GAPs over GTPases presents 
an interesting regulatory quagmire and puts a premium on sites of expression and subcellular 
localization.  
Since we are interested in understanding how drugs of abuse hijack the mechanisms 
that control synaptic plasticity, we focus on the nucleus accumbens (NAc), a region of the 
ventral striatum containing primarily GABAergic medium spiny neurons that receive heavy 
dopaminergic innervation from the ventral tegmental area and glutamatergic inputs from the 
prefrontal cortex87,184. Based on extensive behavioral data, the nucleus accumbens is 
frequently called the “reward center” of the brain94,95,121,246-248. mRNA-Seq technology3 was used 
to identify 31 Rho-GEF, 26 Rho-GAP and 14 Rho-GTPase genes whose transcripts are expressed 
at significant levels in the adult mouse NAc (Eipper-Mains, J.E., unpublished observations). 
Official gene names, synonyms and associated identifiers for all annotated Rho-GEF, Rho-GAP 
and Rho-GTPase genes in the mouse genome are provided in Supplementary Table 1. 
  The epicenter of the dendritic spine is the postsynaptic density (PSD), an electron 
dense structure composed of over 500 proteins, including scaffolds, ligand gated ion 
channels, receptors and signaling molecules249-251. In order to focus on the Rho-GEFs, GAPs and 
GTPases that are localized to the PSD, we compared our list of expressed transcripts to the 
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forebrain PSD proteome66,252,253. Ten of the Rho-GEFs expressed at significant levels in the NAc 
have been identified in purified PSDs or otherwise localized to the PSD254 (J E-M, unpublished 
observations). Official gene names, synonyms and SMART structures of the major neuronal 
isoforms for these Rho-GEFs are shown in Fig. 4.1; five terminate with a PDZ-binding motif and 
five include an SH3 domain. Of the Rho-GTPases expressed in the NAc, only Rac1 and RhoG 
have been localized to the PSD (J E-M, unpublished observations). Localization to the PSD puts 
these Rho-GEF/Rho-GTPase pairs in a unique position to respond rapidly to extracellular 
stimuli and modify the actin cytoskeleton in a manner dependent on synaptic activity. Of the 
Rho-GAPs expressed in the NAc, only 3 are known to localize to the PSD (AU040829, Bcr, 
D15Wsu169e) (J E-M, unpublished observations). While Rho-GAPs clearly play an integral part 
in the regulation of Rho-GTPase activity, their role in synaptic plasticity is outside the scope of 
this review. We focus our review on how the PSD-localized Rho-GEFs are regulated by 
extracellular and intracellular signals and the roles they might play in modulating dendritic 
spine function.  
 With respect to dendritic spine dynamics, the best characterized Rho GTPases are 
Rac1, RhoA and Cdc42. Within spines, Rac1 and RhoA seem to play antagonistic roles, with 
Rac1 promoting spine formation and growth and RhoA promoting spine retraction and 
decreases in spine density241,255,256. Cdc42 also promotes spine formation and is present in 
spines227,257, but has not been localized to the PSD. We begin with a review of the Rho-GEFs 
that preferentially activate Rac1 before moving on to those that activate RhoA and Cdc42. 
Rac1-Specific Rho-GEFs 
Tiam1 
Tiam1 (T-cell lymphoma invasion and metastasis 1) is a Rac1-specific GEF with a single 
Dbl homology-pleckstrin homology (DH-PH) domain near its C-terminus, a PDZ-binding motif   
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Figure 4.1 Rho-GEFs and Rho-GTPases expressed in the NAc and localized to the PSD 
Gene diagrams are drawn to scale and represent SMART structures (http://smart.embl-heidelberg.de/) 
with several modifications (see Supplementary Table 2). Abbreviations: C1, Protein kinase C conserved 
region 1 (C1); C2, Protein kinase C conserved region 2 (CalB); EH, Eps15 homology domain; IQ, Short 
calmodulin-binding motif containing conserved Ile and Gln residues; PDZ, Domain present in PSD-95, 
Dlg, and ZO-1/2; PH, Pleckstrin homology domain; RasGEF, Guanine nucleotide exchange factor for Ras-
like small GTPases; RasGEFN, Guanine nucleotide exchange factor for Ras-like GTPases, N-terminal motif; 
RBD, Raf-like Ras-binding domain; RhoGAP, GTPase-activator protein for Rho-like GTPases; RhoGEF, 
Guanine nucleotide exchange factor for Rho/Rac/Cdc42-like GTPases; SEC14, Domain in homologues of 
a S. cerevisiae phosphatidylinositol transfer protein (Sec14p); SH3, Src homology 3 domains; SPEC, 
Spectrin-like repeats. 
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at its C-terminus, and an additional PH domain closer to its N-terminus (Fig. 4.1)258. 
Additionally, Tiam1 has an internal PDZ domain that binds to the C-terminal peptide sequence 
Tyr-Tyr-(Phe/Ala), although neuronal interaction partners have not yet been identified258. 
When expressed in fibroblasts, Tiam1 induces membrane ruffling and a morphology 
resembling that of constitutively activated Rac1259. Interestingly, it is the more N-terminal PH 
domain of Tiam1 that is essential for its membrane localization, and deletion of this domain 
leads to cytosolic dispersal and a lack of induced membrane changes260. Studies in 
neuroblastoma lines demonstrated that over-expression of Tiam1 increases Rac1-dependent 
neurite outgrowth and insensitivity to RhoA-induced neurite retraction261. While Tiam1 was 
not identified in purified rat forebrain PSDs66,252, immunogold electron microscopy 
demonstrates that Tiam1 is intercalated into the PSD254. This study, which was the first to 
examine Tiam1 in primary neurons, demonstrated that Tiam1 is necessary for the elaboration 
of a full dendritic arbor. Neurons transfected with RNAi targeted against Tiam1 showed a 
dramatic reduction in spine density, and the remaining spines were longer and more 
filopodial than spines in control cultures254.  
Neurons expressing Tiam1 RNAi also exhibited a sharp decrease in miniature 
postsynaptic currents, indicating a functional as well as a morphological change254. The ability 
of Tiam1 to interact directly with the NR1 NMDA receptor subunit, but not with any of the NR2 
subunits, presumably contributes to this deficit (Fig. 4.2A). Stimulation of NMDA receptors in 
control cultures leads to an increase in spine density and size; neurons expressing Tiam1 RNAi 
showed no such changes in spine morphology254. This result is particularly compelling because 
it presents a strong functional connection for the interaction of Tiam1 and NR1. Further linking 
NMDA receptors to Tiam1 signaling, Tiam1 is phosphorylated on unknown Thr residues by 
CamKII and protein kinase C (PKC), enhancing its GEF activity about 2-fold262,263 (Fig. 4.2A). 
Given that CamKII and PKC are indirectly activated by calcium264,265 and both represent major   
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Figure 4.2 Rac-specific GEFs at the PSD 
(A) Tiam1 with NR1 subunit of NMDA receptor, EphB and TrkB. (B) Kalirin7 with PSD-95, PI-3-P/PI-3,5-P2, 
NR2B subunit of NMDA receptor, EphB, Cdk5, and AF-6/N-cadherin. (C) Arhgef7/β-Pix with 
CamKK/CamKI/PKA, GluR2/3 subunit of AMPA receptor via GIT1/liprin-α/GRIP, Pak, Shank, and EphB. (D) 
Rasgrf2 with Cdk5, NMDA and AMPA receptors. 
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components of the PSD66, the anchoring of Tiam1 to NMDA receptors may enhance the 
response of the synapse to the calcium influx that results from NMDA receptor stimulation266. 
 In addition to NMDA receptors, Tiam1 also forms a stable interaction with the receptor 
tyrosine kinase EphB2267 (Fig. 4.2A). EphB2 is stimulated by its presynaptic binding partner 
EphrinB, increasing dendritic spine number and size268. Stimulation of cultured neurons with 
EphrinB leads to a clustering of Tiam1 at the sites of new synaptic contacts. At these sites, 
Tiam1 and EphB2 form a stable complex with EphB2 binding to the N-terminal PH domain of 
Tiam1. As a result, EphB2 phosphorylates Tiam1 at Tyr829267 (Fig. 4.2A). In COS7 cells, a 
phosphomimetic point mutant at this site leads to an increase in Rac1 activation269. 
Importantly, RNAi knockdown of Tiam1 ablates the ability of activated EphB2 to increase spine 
formation in cultured hippocampal neurons, indicating that this pathway is Tiam1-
dependent267. The interaction of Tiam1 with both NMDA receptors and EphB2 begins to paint 
an interesting picture of an important molecular complex at the PSD. EphB2 has repeatedly 
been shown to be important for NMDA receptor clustering and function270-273. Additionally, 
stimulation of both EphB2268,270 and NMDA receptors274 has been implicated in the growth and 
formation of new spines. As a direct interactor with both proteins, Tiam1 is well-positioned to 
integrate voltage-sensitive, ligand-gated ion channel signaling and receptor tyrosine kinase 
signaling to effect activity-dependent changes in the actin cytoskeleton. 
 Finally, Tiam1 interacts with another receptor tyrosine kinase, TrkB269 (Fig. 4.2A). The 
binding of BDNF to TrkB has long been known to be important for the formation and 
maturation of synapses275. Tiam1 interacts with TrkB via its N-terminal PH domain and is 
phosphorylated on Tyr829 (as with EphB2)269. Expression of a non-phosphorylatable Tiam1 
mutant (Tyr829Phe) blocked the BDNF-induced increase in dendritic spines, demonstrating an 
essential role for phosphorylation at this site269. Although a Tiam1 knockout mouse has been 
created and is viable276, it has primarily been used for cancer research. 
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Kalirin7 
In the adult brain, Kalirin7, with a single GEF domain specific for Rac1 and RhoG, is the 
most abundant splice variant of the Kalrn gene277,278 (Fig. 2.1); several larger Kalirin isoforms, 
with a second GEF domain specific for RhoA, are expressed at lower levels, but are not 
localized to the PSD279-282. Kalirin7 terminates with a PDZ-binding motif and it is estimated that 
the average hippocampal PSD, which contains about 20 NMDA receptors and 15 AMPA 
receptors249, contains 10 copies of Kalirin7133. At the N-terminus of Kalirin7 is a Sec14p domain 
that binds phosphatidylinositol-3-phosphate and phosphatidylinositol-3,5-bisphosphate and 
is essential for membrane localization283; this is followed by 9 spectrin-like repeats (Fig. 2.1 and 
2.2B). 
A yeast two-hybrid screen with the PDZ-binding motif of Kalirin7 identified 16 PDZ 
domain-containing interactors284. Given that these PDZ domain-containing proteins interact 
with a variety of receptor subtypes (e.g. NMDA, AMPA, 5-HT), protein kinases (e.g. PKA, CamKII) 
and filamentous actin, this places Kalirin7 in a unique position to integrate a wide variety of 
signals at the PSD285. The interaction of Kalirin7 with PSD-95 decreases its ability to activate 
Rac1 (Fig. 2.2B). Kalirin7 was identified in the NMDA receptor interactome after affinity-
purification using a peptide from the C-terminus of the NR2B subunit66; this interaction was 
verified by co-immunoprecipitation of Kalirin7 with NR2B (Kiraly, D.D., unpublished 
observations). Consistent with this, PSDs purified from mice lacking Kalirin7 have decreased 
levels of NR2B133. Unlike Tiam1, Kalirin7 does not co-immunoprecipitate with NR1254. Tiam1, 
through its association with the NR1 subunit254, and Kalirin7, through its association the NR2B 
subunit, may serve to modulate critical signaling steps downstream of specific NMDA receptor 
subsets. 
 The ability of Kalirin7 to increase spine formation in vitro has been demonstrated in 
cultured cortical and hippocampal neurons284,286,287. Perhaps most compelling, Kalirin7 
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expression in otherwise aspiny interneurons leads to the formation of spine-like structures 
that acquire apposing presynaptic terminals and appear to function as active synapses288. 
Recently, these findings were validated in vivo with the development of a Kalirin7 knockout 
mouse. These mice display a decrease in dendritic spine density in the hippocampus as well as 
impaired hippocampal LTP and focal hippocampus-dependent learning impairments133.  
Much has been done to clarify the intracellular molecular interactors with Kalirin7. In cultured 
cortical neurons, Kalirin7 is essential for EphB2-induced spine formation287,289 (Fig. 2.2B). 
Stimulation of cell cultures with clustered EphrinB led to a modest tyrosine phosphorylation 
signal on Kalirin7, although the location of the phosphorylated residue was not established287. 
Kalirin7 and Tiam1 may work in parallel pathways to propagate signals downstream of this 
receptor tyrosine kinase. 
It has been suggested that the N-terminus (Thr95) of Kalirin7 is phosphorylated by 
CamKII and that phosphorylation at this site is essential for Kalirin7 to display GEF activity290 
(Fig. 2.2B). However, mutation of Thr95, which is not a consensus CamKII site264,291,292, to a non-
phosphorylatable Ala (Thr95Ala) did not eliminate its GEF activity, and the GEF activity of 
Kalirin7 and shorter splice variants lacking this region (ΔKal7) are indistinguishable in 
vitro283,293,294. Co-immunoprecipitation of Kalirin7 and GluR1 led Xie and colleagues to 
hypothesize that Kalirin7 is necessary for the movement of GluR1 into newly formed dendritic 
spines upon NMDA receptor stimulation of cortical cultures290. Mice genetically lacking Kalirin7 
have normal levels of GluR1 in both tissue homogenates and purified PSDs133, so Kalirin7 is not 
essential for AMPA receptor localization in vivo. 
The Kalirin7 PDZ-binding motif interacts with the PDZ domains of AF-6/Afadin, 
Neurabin and Spinophilin, each of which can bind directly to filamentous actin. AF-6 also 
mediates the interaction of Kalirin7 with N-cadherin, a trans-synaptic protein that forms 
homophilic interactions with presynaptic N-cadherin284,295 (Fig. 2.2B). N-cadherin plays an 
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important role in the regulation of dendritic spine morphology296,297. Stimulation of neuronal 
cultures with clustered N-cadherin results in an increase in dendritic spine size and recruits AF-
6, Kalirin7 and Rac1 into dendritic spines295. When expression of all isoforms of Kalirin was 
reduced using RNAi, clustered N-cadherin was no longer able to change dendritic spine 
morphology295. 
 Kalirin7 is phosphorylated at a single site (Thr1590) by Cdk5 (Fig. 2.2B), a synaptically-
localized serine/threonine kinase known to play an important role in synapse development 
and modulation; Cdk5 is localized to membranes and activated by binding to p35 or p39, not 
to a cyclin114,120,294,298-303. Phosphorylation of Thr1590 increases the GEF activity of Kalirin, with the 
phosphomimetic mutant (Thr1590Asp) showing a two-fold increase in activity over the non-
phosphorylatable mutant (Thr1590Ala). Mutation of Thr1590 to Asp or Ala did not affect the ability 
of Kalirin7 to increase spine density. While neurons expressing Thr1590Asp-Kalirin7 exhibited 
increased dendritic spine size, neurons expressing Thr1590Ala-Kalirin7 did not294. The fact that 
Kalirin7 knockout mice show a decrease in Cdk5 levels in purified synaptosomes and PSDs133 
suggests a role for reciprocal regulation of Kalirin7 and Cdk5 in vivo as well as in vitro. 
Arhgef7/β-Pix 
 Arhgef7 (β-Pix) was identified based on its ability to activate Rac1, Cdc42 and Pak (p21 
activated kinase)304 (Fig. 2.2C). Two isoforms of β-Pix, β1 and β2, which differ only at their C-
termini, are the major ones expressed in the mammalian brain305. The β1 isoform C-terminus 
has a coiled-coil domain and a PDZ-binding motif while the β2 isoform C-terminus has a 
serine-rich region (Fig. 2.2C)305. The N-terminal SH3 domain of β-Pix binds to Pak, recruiting 
Pak to Rac1- and Cdc42-induced adhesion complexes; mutations that inactivate this SH3 
domain lead to mislocalization of Pak304. Crystal structure analysis detailed the interactions of 
the SH3 domain of β-Pix with Pak306. β-Pix is phosphorylated by Pak on Thr526, increasing its 
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membrane localization and boosting its GEF activity, ultimately eliciting neurite formation in 
PC12 cells307. 
 When studied in primary hippocampal cultures, it became clear that β-Pix is recruited 
to synapses by GIT1 (G-protein-coupled receptor-kinase-interacting protein 1), which is 
present in the PSD66,308. GIT1 is a ubiquitously expressed ARF-GAP (ADP-ribosylation factor 
GTPase Activating Protein) that is enriched at the PSD and complexes with AMPA receptor 
subunits in the rat brain through its association with liprin-α309. Liprin-α is a multi-functional 
protein with a number of known interacting proteins including the GRIP/ABP family 
(glutamate receptor interacting proteins) of multi-PDZ domain containing proteins. Through 
their PDZ domains, GRIPs at the PSD interact with a number of different proteins including the 
AMPA receptor subunits GluR2 and GluR3, the receptor tyrosine kinase EphB2 and the 
neuronal Ras-GEF GRASP-1309,310. 
The GIT1-binding domain of β-Pix lies just upstream of the C-terminal coiled-coil and 
the C-terminal serine-rich regions of β1- and β2-Pix, respectively305. The ability of GIT1 to 
recruit β-Pix to synapses is necessary for the formation of new dendritic spines with apposing 
presynaptic terminals. When the β-Pix-binding domain of GIT1 was deleted, β-Pix showed a 
more diffuse localization, leading to a multitude of aberrant cell protrusions that were not 
associated with presynaptic terminals. The GEF activity of β-Pix is necessary for the formation 
of new spine-like structures in hippocampal neurons308. GIT1 is not solely responsible for the 
localization of β-Pix to synapses. β1-Pix binds to the PDZ domain of Shank via its C-terminal 
PDZ-binding motif250 or its coiled-coil domain311 and over-expression of Shank recruits 
additional β-Pix to dendritic spines311 (Fig. 2.2C), blocking actin bundling312. While β-PIX does 
not interact with the PDZ domains of PSD95, Sap97, S-Scam, GRIP1, Lin7 or Densilin, it directly 
interacts with the PDZ domain of Scribble, a protein most studied in cancer biology and 
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epithelial polarity; in PC12 cells stimulated with KCl, Scribble recruits β-Pix to the plasma 
membrane313. 
 β-Pix modulates Ca2+-dependent intracellular signaling. β-Pix co-immunoprecipitates 
with CamKK (CamK-kinase) in transfected cells and rat brain lysates314. This interaction is 
mediated via the SH3 domain of β-Pix, the region also known to interact with Pak. β-Pix is 
phosphorylated by CamKI, a downstream target of CamKK, on Ser516, a site known to be 
phosphorylated by PKA315. The GEF activity of β-Pix is stimulated in a Ca2+-dependent manner 
and mutation of Ser516 to a non-phosphorylatable mutant (Ser516Ala) obviated the Ca2+-
dependent changes in Rac1 activation314. Expression of dominant negative CaMKI, Ser516Ala-
βPIX, or siRNA for either CaMKI or β-Pix resulted in a marked decrease in dendritic spine 
density in cultured neurons314. This study clearly demonstrates a role for β-Pix in calcium-
calmodulin signaling cascades.  
 While β-Pix has not been directly linked to any cell-surface receptor in mammals, 
deletion of the corresponding Drosophila gene leads to decreased synaptic levels of the 
glutamate receptor subunit GluRIIA316. In mice, β-Pix is linked to GluR2/3 AMPA receptor 
subunits via the GIT1/liprin-α/GRIP complex described above. Disruption of the GIT1/liprin-α 
interaction results in decreased AMPA receptor clustering in cultured neurons309. Taken 
together, the Drosophila and mouse data suggest a role for β-Pix in proper postsynaptic AMPA 
receptor targeting via its interaction with GIT1/liprin-α/GRIP. Additionally, GIT1 is indirectly 
recruited to synapses by EphrinB stimulation of the EphB2 receptor tyrosine kinase317. Three 
PSD Rho-GEFs, β-Pix, Tiam1, and Kalirin7, mediate morphogenic signals downstream of 
EphB2267,287,318,319. 
Rasgrf2 
 Rasgrf2 is unique in that it contains both a Rho-GEF DH-PH domain as well as a Ras-
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GEF domain (Fig. 2.1). Rasgrf2 has a C-terminal type II PDZ-binding motif with no known 
binding partners245. Ras promotes the creation of larger spines receiving excitatory synapses 
and is normally held in check by SynGAP320. Interestingly, Rasgrf2 has been linked to the 
Cdk5/p35 signaling pathway in neurons. Cdk5 phosphorylates Rasgrf2 on Ser737, decreasing its 
Rac1-GEF activity, but has no effect on its ability to activate Ras321 (Fig. 2.2D). Additionally, 
while Rasgrf2 is typically found along dendrites in basal conditions, co-expression of p35 and 
Cdk5 leads to the retraction of Rasgrf2 into the cell soma321. This is another indication of the 
many ways in which Cdk5 activity affects PSD-GEF function. The Ras-GEF domain of Rasgrf2 
has been implicated in the control of both NMDA and AMPA glutamate receptors, but will not 
be discussed here as we are focusing on Rho-GEFs at the PSD322-324. 
RhoA/Cdc42-Specific Rho-GEFs 
Ngef/Ephexin1 
 In the NAc, transcripts encoding Ngef (Ephexin1) are more prevalent than those 
encoding any other Rho-GEF (JE-M, unpublished observations). Ephexin1 has C-terminally 
located DH, PH and SH3 domains (Fig. 4.1). Ephexin1 activates Rac1, Cdc42, and RhoA325; 
different signaling pathways shift its specificity towards Rac1/Cdc42 or towards RhoA, altering 
the downstream response. Ephexin1-mediated activation of Rac1 has been studied in the 
context of axon outgrowth and neuronal development325-328. While the events leading to Rac1 
activation by the Rho-GEFs discussed above are generally well characterized, the events 
involved in Ephexin1-mediated Rac1 and Cdc42 activation are not well understood. Pak, which 
is involved in β-Pix activation of Rac1, demonstrates increased activity in the context of 
Ephexin1-mediated axonal outgrowth325. Pak may complex with Ephexin1 and shift its GEF 
activity towards Rac1/Cdc42 activation and actin polymerization325 (Fig. 4.2A). 
A great deal more is known about the role of Ephexin1 in RhoA activation. The 
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generation of an Ephexin1 knockout mouse facilitated studies into the role of Ephexin1 in 
axonal outgrowth and growth cone collapse in cultured retinal ganglion cells (RGCs)326. 
Ephexin-/- RGCs exhibit the same number of neurites per cell but have significantly shorter 
axons than their wild-type counterparts326. Incubation of Ephexin1-/- RGCs with EphrinA1 does 
not elicit the wild-type phenotype of growth cone collapse, implicating an EphA4/Ephexin1 
interaction in the control of EphrinA1-induced growth cone collapse. It should not go 
unmentioned that Ephexin1 knockout mice show no overt axonal phenotype in vivo326, 
perhaps due to functional redundancy amongst RhoGEFs. 
The DH-PH domain of Ephexin1 binds the kinase domain of EphA4 in cultured 
fibroblasts325; a direct interaction between EphA4 and Ephexin1 has not been demonstrated 
by co-immunoprecipitation in neurons326. Ephexin1 is phosphorylated following EphrinA1 
stimulation of EphA4 receptors, and this phosphorylation event is required for growth cone 
collapse in cultured RGCs326. Stimulation of the EphA4 receptor by EphrinA1 in neuronal 
cultures results in EphA4 autophosphorylation and recruitment of two kinases, Cdk5/p35 and 
Src, to EphA4 at the PSD301,327. EphrinA1 binding causes a loss of dendritic spines and a 
corresponding decrease in miniature excitatory postsynaptic current (mEPSC) frequency301. 
The EphA4 receptor co-immunoprecipitates with Cdk5/p35 from rat brain extracts, suggesting 
a direct interaction in vivo301. 
Activated EphA4 phosphorylates the recruited Cdk5, stimulating its kinase activity and 
its subsequent phosphorylation of Ephexin1 at three sites, Thr41, Thr47, and Ser139301 (Fig. 4.3A). 
Mutant Ephexin1, in which the Cdk5 target residues are replaced with non-phosphorylatable 
Ala residues, eliminates the ability of Src to phosphorylate Ephexin1 on Tyr87; Ephexin1 with 
Glu at these same sites supports robust EphrinA1/EphA4-mediated Ephexin1 phosphorylation 
at Tyr87301. The kinase domain of EphA4 does not directly phosphorylate Ephexin1 at Tyr87326. 
Rather, EphA4 and Src demonstrate ligand-induced association with subsequent stimulation  
107 
 
 
Figure 4.3 Rho/Cdc42-specific GEFs at the PSD 
(A) Ngef/Ephexin1 with Pak, EphA4, Src, and Cdk5. (B) Arhgef2/Lfc/GEF-H1 with a microtubule, 
Spinophilin, GluR1 subunit of AMPA receptor, ERK1/2, AKAP121/PKA, and 14-3-3. (C) 
Arhgef9/Collybisitin with Gephyrin and Neuroligin-2. (D) Itsn1/Intersectin-L with N-WASP, EphB2, and 
Arp2/3. 
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of the tyrosine kinase activity of Src327. Activated Src phosphorylates Ephexin1 at Tyr87, an 
event that shifts the GEF activity of Ephexin1 towards RhoA and ultimately results in growth 
cone collapse326,329 (Fig. 4.3A). Inhibition of Src-dependent phosphorylation of Ephexin1 at 
Tyr87 obviates EphrinA1/EphA4-induced repulsive axon guidance in retinal axons327. Similarly, 
analysis of hippocampal cultures from Cdk5-/- mice, revealed an obligatory role for Cdk5 in the 
EphrinA1-mediated loss of dendritic spines and decrease in mEPSC frequency301. 
 There is evidence in cultured cells that the FGF and EphA receptors form hetero-
oligomers and cross-activate one another330. Activated FGF receptor phosphorylates Ephexin1 
at several tyrosine residues, including Tyr87, and shifts its GEF activity towards RhoA329. While 
the FGF receptor is known to be present at presynaptic terminals and is expressed in 
astrocytes331, it is not present at the PSD66,252 and is thus unlikely to play a major role in 
dendritic spine actin dynamics. 
Arhgef2/Lfc/GEF-H1 
Arhgef2 (Lfc; GEF-H1) is a RhoA-specific GEF with a single DH-PH domain and two 
coiled coil regions near its C-terminus332 (Fig. 4.1). Under basal conditions Lfc is found 
predominantly in dendritic shafts, where it interacts with microtubules via its PH domain332,333. 
In cultured neurons, NMDA receptor activation causes the rapid translocation of Lfc into 
dendritic spines333 (Fig. 4.3B). A recent study examining Lfc localization in primate cortex at 
the electron micrograph level also concluded that Lfc was primarily localized to dendritic 
shafts under basal conditions, translocating rapidly into spines upon synaptic stimulation334. 
Once in spines, Lfc interacts with Spinophilin and Neurabin, which bind filamentous actin333 
(Fig. 4.3B). One study, by Ryan and colleagues, demonstrated that over-expression of Lfc in 
cultured neurons produces a decrease in spine size and an increase in spine density333. 
Consistent with this, a more recent study by Kang and colleagues demonstrated that 
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expression of dominant negative Lfc or shRNA targeted to Lfc increased spine size335. However, 
in the more mature cultures studied by Kang and colleagues, reductions in Lfc action 
increased spine density, perhaps suggesting developmental alterations the Lfc/RhoA 
pathway335. Activation of RhoA has typically been associated with decreased spine 
density241,336. 
 Even under basal conditions, Kang and colleagues found Lfc in the PSD, a finding 
supported by PSD proteomics studies66,252. Based on both proteomic analyses of AMPA 
receptor complexes and co-immunoprecipitation with the GluR1 and GluR2 AMPA receptor 
subunits, Lfc interacts with AMPA receptors. Incubation of hippocampal cultures with an 
AMPA receptor antagonist normally leads to a decrease in dendritic spine density; in neurons 
expressing Lfc-shRNA, this effect is ablated335. Suppression of AMPA receptor function 
normally increases RhoA activity; this response is diminished when Lfc expression is reduced 
using Lfc-shRNA, and stimulation of AMPA-R inhibits Lfc activity and RhoA signaling335 (Fig. 
4.3B). Lfc seems to play a crucial role in RhoA-mediated spine retraction. 
The GEF activity of Lfc is also controlled by phosphorylation337-339. Phosphorylation by kinases 
Aurora A/B (at Ser885) or Cdk1/Cyclin B (at Ser959) decreases Lfc-RhoGEF activity337 while 
phosphorylation by ERK1/2 (at Thr678) enhances Lfc-RhoGEF activity338. PKA phosphorylates 
Ser885, with concomitant AKAP121 binding to Lfc in HEK293 cells; the phospho-specific 
scaffolding protein, 14-3-3, then binds to P-Ser885-Lfc, decreasing the GEF activity of Lfc340 (Fig. 
4.3B). Though proteomics studies have localized PKA to the PSD66,252, the role of PKA-
dependent phosphorylation in the regulation of Lfc-RhoGEF activity in neurons remains to be 
studied. 
Arhgef9/Collybistin 
Arhgef9 (Collybistin) is a brain-specific Rho-GEF with a single DH-PH domain that is 
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specific for Cdc42341 (Fig. 4.1). Two isoforms of Collybistin are expressed in brain: Collybistin1 
includes an N-terminal SH3 domain and a C-terminal coiled-coil domain; Collybistin2 lacks 
these two domains342. Although the identities of the specific players regulating Collybistin-
RhoGEF activity and localization remain elusive, it is clear that its SH3 domain plays a key role 
in these interactions343.  
 Collybistin is expressed broadly throughout the forebrain and cerebellum from early 
embryonic life through adulthood342,344. Collybistin was originally discovered as an interactor 
with Gephyrin, a protein essential for the formation of inhibitory postsynaptic structures in 
brain and spinal cord341,342. The linker region between the SH3 and DH domains is essential for 
the Collybistin-Gephyrin interaction345 (Fig. 4.3C). Collybistin with an active PH domain and an 
intact Gephyrin-binding site is essential for the postsynaptic localization of Gephyrin in 
dendrites of cultured cortical neurons343. A patient exhibiting hyperekplexia and epilepsy, 
both potentially caused by a decrease in inhibitory neurotransmission, had a mutation that 
disrupted the SH3 region of Collybistin343. Expression of this mutant protein in cultured cortical 
neurons led to a loss of GABAA receptor clustering343. Another patient with a balanced 
chromosomal translocation leading to disruption of the Collybistin gene displayed disturbed 
sleep cycles, increased anxiety, epileptic seizures and mental retardation346. Collybistin clearly 
plays a key role in the regulation of inhibitory transmission in humans as well as rodents. 
 The Collybistin knockout mouse displays normal locomotor activity, but anxiety-like 
behavior is increased dramatically and spatial learning is grossly impaired347. In the 
hippocampus and amygdala of the Collybistin-/- mouse, GABAA receptor expression is greatly 
reduced and inhibitory neurotransmission is decreased. Interestingly, these mice display 
enhanced CA1 LTP in hippocampal slices while LTD plasticity is impaired347. In contrast, 
induction of LTP in the dentate gyrus of Collybistin-/- mice is greatly decreased348. Both 
Collybistin and Gephyrin interact with Neuroligin-2, a trans-synaptic scaffolding protein 
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essential for the formation of inhibitory synapses349 (Fig. 4.3C). The interaction of Collybistin 
and Neuroligin-2 enhances the ability of Collybistin to recruit Gephyrin to synapses, which in 
turn leads to the formation of more inhibitory synapses in cultured neurons349. Taken together, 
these studies demonstrate a clear role for Collybistin in the normal formation of inhibitory 
synapses and the balance of excitatory/inhibitory transmission in the mammalian forebrain, 
but leave unanswered the role of the GEF domain of Collybistin in the nervous system. 
Itsn1/Intersectin-L 
The longer neuron-specific splice variant of the Itsn1 gene, Intersectin-L, includes C-
terminal DH, PH and C2 domains as well as several common protein-protein interacting 
regions it shares with the shorter, ubiquitously expressed splice variant, Intersectin-S350-352 (Fig. 
4.1). The common region includes two Eps15 homology domains, several coiled-coil regions, 
and five SH3 domains. Intersectin-S affects neuronal endocytic vesicle formation352. The 
tandem DH-PH domains of Intersectin-L interact specifically with Cdc42 to stimulate its 
GTPase activity, and over-expression of Intersectin-L induces formation of filopodia in 
fibroblasts350. 
Regulation of the Rho-GEF activity of Intersectin-L occurs at many levels. Activity 
assays demonstrate more robust GEF activity in C-terminal DH-PH tail constructs than in full-
length Intersectin-L, suggesting a role for N-terminal modulation of the GEF activity of 
Intersectin-L. N-WASP (Neuronal Wiskott-Aldrich Syndrome Protein), which activates the 
Arp2/3 actin-nucleating complex, interacts directly with the SH3 domains of Intersectin-L, 
stimulating its GEF activity; the Intersectin-L/N-WASP complex can be immunoprecipitated 
from transfected cells and from native brain extracts350 (Fig. 4.3D). The N-WASP/Intersectin-L 
interaction relieves Intersectin-L autoinhibition and may stabilize the GEF domain interaction 
with GDP-bound Cdc42, catalyzing its activation350. Additionally, the kinase domain of the 
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receptor tyrosine kinase EphB2 interacts with the N-terminus of Intersectin-L, activating Cdc42 
in hippocampal neurons; the Intersectin-L/ EphB2 complex can be immunoprecipitated from 
extracts of transfected cells353 (Fig. 4.3D). 
N-WASP links Cdc42 to the actin cytoskeleton via its ability to stimulate the Arp2/3 
complex, causing actin-nucleation239,350,354. Co-localization of EphB2 and N-WASP with 
Intersectin-L and F-actin in dendritic spines suggests a model in which EphB2 and N-WASP act 
synergistically to activate Intersectin-L GEF activity352,353 (Fig. 4.3D). Concomitant binding of N-
WASP to the Intersectin-L/Cdc42 complex results in relief of N-WASP autoinhibition and a 
dose-dependent N-WASP-mediated stimulation of Intersectin-L GEF activity239,350. Activated N-
WASP stimulates the Arp2/3 complex, causing actin polymerization239,350. N-WASP plays roles 
both up- and downstream of Intersectin-L, highlighting the importance that multimolecular 
complexes play in the regulation of the actin cytoskeleton355. 
The Itsn1 gene has been implicated in Down Syndrome (DS), with DS neurons exhibiting 
abnormal dendritic spine morphology and altered endosomal pathways351. The Itsn1 gene is 
located on human chromosome 21, the same chromosome present in extra copy number in 
Down Syndrome, further suggesting a role for Itsn1 in the pathophysiology of Down 
Syndrome352. 
Bcr 
Bcr (Breakpoint cluster region) negatively regulates cell proliferaton and oncogenic 
transformation356. Bcr and the closely related protein Abr are the only two GTPase-activating 
proteins that specifically inactivate Rac1357. Bcr both turns Rac1 on (via its GEF domain) and 
inactivates Rac1 (via its RhoGAP domain) (Fig. 4.1). Bcr exhibits GEF activity towards Rac1, 
Cdc42, and RhoA245. In addition to its DH-PH and GAP domains, Bcr has a serine/threonine 
kinase domain and a C-terminal PDZ-binding motif that interacts with the PDZ domain of AF-
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6/Afadin, a protein known to bind Ras and filamentous actin356. The kinase domain of Bcr 
phosphorylates AF-6 near its PDZ domain, promoting a direct interaction between Bcr and AF-
6356. While the impact of the Bcr/AF-6 interaction on the GEF activity of Bcr remains to be 
determined, the existence of this phosphorylation-mediated interaction raises the possibility 
that phosphorylation events can regulate interactions between other PDZ-binding motif-
containing Rho-GEFs and their PDZ-domain-containing partners245. 
Bcr is among a set of genes expressed very early in development358. Full-length Bcr contributes 
to NGF-independent neurite formation in PC12 cells359, while a fusion construct including the 
GEF domain but not the RhoGAP domain suppresses neurite outgrowth359. Mice in which both 
Bcr and Abr are knocked out show a number of glial cell developmental abnormalities which 
then precipitate neuronal abnormalities in the cerebellum and midbrain360. A genomic 
translocation resulting in a fusion between Bcr and the Abl kinase is seen in 95% of patients 
with chronic myelogenous leukemia (CML)361. 
Conclusions 
 As primary regulators of the actin cytoskeleton, Rho-GEFs play the role of conductors 
in the elegant symphony that is synaptic plasticity. A preponderance of human and animal 
studies demonstrate that a dynamic balance of synapse formation and elimination is 
necessary for normal cognition and neuronal function. The delicate balance that is struck 
between GEF-GTPase activity and the actin cytoskeleton includes several GEFs regulated by 
the same pathways. A number of GEFs have been shown to be downstream of NMDA 
receptors (Tiam1, Kalirin7, Rasgrf2, Lfc) and/or Ephrin receptors (Tiam1, Kalirin7, β-Pix, 
Ephexin1, Intersectin-L), two receptor systems critically linked to the plasticity of the 
postsynaptic neuron319,362. Additionally, while all of these proteins have been linked to a variety 
of intracellular signaling cascades, it is noteworthy that a number of them (Kalirin7, Rasgrf2, 
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Ephexin1) have been linked to Cdk5, a protein known to have myriad effects on the structure 
and function of PSDs and spines120,301,303,363. Additionally, Tiam1, Kalirin7 and β-Pix have all been 
linked to calcium-calmodulin kinase signaling pathways, which have a plethora of functions at 
the synapse and play essential roles in synaptic plasticity264,314. Clearly, this puts a premium on 
localization of the GEF, its target GTPase, and any other signaling molecules that influence 
their function.  
 One of the quandaries raised by this review of the literature is the disparity between 
cell culture studies and in vivo models of these Rho-GEFs. While cell culture studies may 
indicate that a specific Rho-GEF is “essential” for dendritic spine formation254,286, the phenotype 
observed in the corresponding knockout animal is often much less profound. Taking Kalirin7 
as an example, cultures expressing shRNA for Kalirin7 have almost no normal dendritic 
spines288; however, Kalirin7 knockout mice display only a 20% decrease in hippocampal spine 
density. While neither the cell culture nor constitutive knockout system is without its 
drawbacks, the disparity between these types of studies suggests that serious consideration 
should be made before interpreting any of these findings in a translational or clinical sense. As 
new and developing technologies (mRNA-Seq, proteomics, phosphoproteomics, etc.) become 
more affordable and accessible to researchers, they will facilitate the integration of seemingly 
solitary signaling pathways into the overlapping web of pathways that is likely occurring in 
vivo. 
 While extensive research has pushed our understanding of dendritic spines forward, 
there is clearly still much more that needs to be determined. Localizing activated Rho-GEFs 
and Rho-GTPases and understanding the kinetics of their activation and inactivation will be 
critical. It will be important to clarify the conditions under which different receptors activate 
different Rho-GEFs and how they interact with their target Rho-GTPases. It is only through the 
clarification of these networks that we will be able to determine their precise role in mental 
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retardation, drug addiction, schizophrenia or the host of other human pathologies that 
demonstrate altered synaptic connectivity. 
Online Supporting Material 
Supplementary tables are available online at: 
    http://intron.ccam.uchc.edu/data/pipeline/jodi/THESIS_supplementary_files/CHAPTER_4 
These materials are also available at the journal of publication: 
    http://pubs.acs.org/doi/suppl/10.1021/cn100012x 
Supplementary table legends 
Supplementary Table 1: Names and accession numbers for all identified M. musculus Rho-
GEFS, Rho-GAPs, and Rho-GTPases expressed in the PSD. 
Gene Symbol, Gene Name, MGI ID, and Entrez ID represent the official names and identifiers 
for each gene as designated by the naming authority. MGI ID and Entrez ID entries are 
hyperlinked to the specific gene page the Mouse Genome Informatics (MGI) and NCBI 
(GenBank) websites. Table includes Synonyms, UniGene IDs, UniProt ID, UniProt Accession, 
Ensemble IDs, and RefSeq IDs. 
 
Supplementary Table 2: Modifications to SMART structures of Rho-GEFs in Fig. 4.1. 
Features changed from SMART database (http://smart.embl-heidelberg.de/) structures are 
provided for each Rho-GEF in Fig. 4.1. Table includes the accession number used in the SMART 
query and provides a reference in support of the changes. Accession numbers are from the 
UniProt (http://www.uniprot.org/) and NCBI (http://www.ncbi.nlm.nih.gov/protein) databases. 
SMART designates segments of low compositional complexity, all of which were removed 
from the gene structures in Fig. 4.1. 
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CHAPTER 5  
Collaborative Bioinformatic Projects 
 
Introduction 
 Collaborative work has been an invaluable part of my graduate education. Through 
collaborative efforts I have been able to explore a number of aspects of biology that I 
otherwise might not have. This chapter provides a brief compilation of some of the additional 
computational work I have done in collaboration with others, much of which has resulted in 
the generation of published studies. 
Alternative exon classification 
 The first year of my time in graduate school was spent learning the basics of Perl 
scripting. My first assignment was the characterization of the transcribed elements of the fruit 
fly (Drosophila melanogaster), mouse (Mus musculus), and human (Homo sapiens) 
transcriptomes. I generated Perl scripts that processed the annotated genes and created files 
with the following alternative exon event classifications: alternative 5’ and alternative 3’ splice 
sites, alternative initiation and termination exons, retained/unprocessed introns, cassette 
exons, mutually exclusive exons, and coordinate exons (Fig. 5.1). 
 My classification of alternative and constitutive regions of the Drosophila genome was 
used in the generation of two recent publications364,365: 
McManus, C.J., Duff, M.O., Eipper-Mains, J. & Graveley, B.R. Global analysis of trans-splicing in 
Drosophila. Proc. Natl. Acad. Sci. U.S.A. 107, 12975-12979 (2010). 
McManus, C.J., et al. Regulatory divergence in Drosophila revealed by mRNA-seq. Genome Res. 
20, 816-825 (2010).  
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Figure 5.1 Classification of common types of alternative splicing events 
Depiction of the alternative splicing events determined by the Perl script I wrote. Constitutive exons are 
shown in blue and alternatively spliced exons are shown in yellow. 
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 Two ongoing projects in the lab are making use of the complete classification of 
Drosophila and Homo transcribed regions for the analysis of alternative splicing. I wrote 
additional Perl and R-programming language scripts to analyze splice junction usage and/or 
exclusion and to provide an output containing a statistical measure of significance (Fisher’s 
Exact Test). These studies are expected to result in publications in the near future. 
Analysis of alternate promoter usage in the Kalrn gene 
 Because of my familiarity with the UCSC Genome Browser, I was asked to assist with 
analysis of the effects of cocaine on a specific Rho GDP/GTP exchange factor (GEF), Kalrn. For 
this paper, I performed many of the necessary bioinformatic analyses. This included 
identification and extraction of alternative promoter sequences, characterization of exons, and 
identification of the corresponding protein domains. 
 Chronic cocaine exposure induces lasting morphological changes at excitatory 
glutamatergic synapses on medium spiny neurons of the striatum87. Modifications to synaptic 
morphology are carried out through rearrangements of the actin cytoskeleton and are largely 
mediated by the activation of the Rho family of proteins68. The Kalrn gene exhibits complex 
alternative splicing and multiple distinct isoforms with different functional domains are 
expressed throughout the body280,281. Full-length Kalrn has two GEF domains, through which it 
activates Rho proteins, as well as additional protein interacting domains277. 
 Chronic cocaine exposure leads to increased expression of a specific Kalirin isoform, 
Kalirin 7, in the striatum. Mice specifically lacking this isoform, which is the major Kalrn isoform 
in the adult rodent brain, exhibit behavioral abnormalities and lack the increased dendritic 
spine density normally observed following chronic cocaine exposure98. 
 I contributed a figure detailing the complex alternative splicing pattern seen in the 
Kalrn gene (Fig. 5.2). 
  
 
Figure 5.2  Structure of the mouse Kalrn gene and major transcripts 
Genomic and transcript information was compiled from websites (http://www.ensembl.org/Mus_musculus/Info/; http://genome.ucsc.edu/cgi-bin/) and 
previously published work (Johnson et al., 2000, McPherson et al., 2002, and McPherson et al., 2004) to create an accurate map of the mouse Kalrn gene and 
the major brain transcripts277,280. Protein domains (http://smart.embl-heidelberg.de/) encoded by groups of exons are indicated. 
 
(Appeared in its original form as Figure 2 from Mains, R.E., Kiraly, D.D., Eipper-Mains, J.E., Ma, X. & Eipper, B.A. Kalrn promoter usage and isoform expression 
respond to chronic cocaine exposure. BMC Neurosci.12, 20 (2011)). 
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This work appeared in a recent publication116: 
Mains, R.E., Kiraly, D.D., Eipper-Mains, J.E., Ma, X. & Eipper, B.A. Kalrn promoter usage and 
isoform expression respond to chronic cocaine exposure. BMC Neurosci 12, 20 (2011). 
EMBOSS silent restriction sites 
 I installed, compiled, and executed the EMBOSS silent program 
(http://emboss.bioinformatics.nl/) to identify potential silent restriction site modifications for 
use in the introduction of specific mutations and features in protein coding genes. These 
contributions are in use in a number of ongoing projects in another lab and will likely be 
included in future publications. 
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CHAPTER 6  
Conclusions & Future Directions 
 
 
Introduction 
 Global analytical approaches generate enormous amounts of data, creating new 
opportunities to address important questions in fundamentally different ways. The studies 
described in the previous chapters provide a framework for many future experiments. 
Experimental approaches 
 The data presented in this thesis were collected over a period of years on a relatively 
limited number of experimental animals, using slightly different cocaine treatment paradigms 
and techniques, and two different sequencing machines. Ideally, these experiments could be 
carried out with larger numbers of mice receiving identical treatments occurring 
simultaneously for all treatment groups. For mRNA experiments using total tissue, it would be 
interesting to use multiplex tags for sequencing RNA from individual animals because this 
would enable us to look for correlations between gene expression changes and differences in 
cocaine responsiveness between individual mice. 
 Additionally, as mentioned in the introduction, all drugs of abuse ultimately cause 
enhanced signaling in the nucleus accumbens (NAc)83. Studies using different drugs of abuse 
and different drug treatment paradigms would therefore be interesting to compare to the 
data presented here. Profiling the molecular differences in the brain between experimenter-
administered and self-administered cocaine could potentially provide insight into the genes 
underlying motivation and drug-seeking behavior. Studies to profile gene expression after 
alternate drugs of abuse, such as morphine, amphetamine, and methamphetamine, would 
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help establish the overlapping signaling pathways common to all drugs as well as those 
unique to a particular drug. 
 The mesolimbic dopamine system is comprised of a variety of cell types. The 
sequencing data presented here therefore derive from a heterogeneous population of cells. A 
number of recent experiments suggest that gene expression differs significantly from one cell 
to the next 31,366-369. A recently developed technique allows one to isolate cell-type specific 
translating RNA using eGFP-tagged ribosomes: the translating ribosome affinity purification 
(TRAP) method 370. In this method, generation of transgenic mice expressing an 
eGFP/ribosomal fusion protein controlled by a cell-type specific driver enables specific 
extraction of labeled polysomes using antibodies to eGFP. The characterization of cell-type 
specific mRNA expression could potentially illuminate important molecules and signaling 
pathways involved in drug abuse that were obscured by the heterogeneity of mixed tissue 
lysates. 
 It would also be interesting to investigate epigenetic modifications to DNA and 
histones as a result of drug exposure using RNA-Seq technology. Epigenetic changes are 
known to occur in many neuropsychiatric disorders371-373, and recent evidence points to a role 
for epigenetics in the response of the brain to drugs of abuse374-378. 
Analytical approaches 
 The methodology underlying high-throughput sequencing is undergoing constant 
improvement, which makes comparisons between recent data sets and older data sets, 
obtained with what was then "state of the art", very difficult. Even using one method and a 
highly expressed gene such as Actb (β-actin), sequence coverage across different exons is far 
from uniform (Fig. 1.2); these differences are even more pronounced when comparisons are 
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made between data sets generated with 37 bp reads and 100 bp reads. Difficulties of this type 
will presumably be minimized as the technology matures. 
 For both editing and alternative splicing, a major impediment to data interpretation is 
the general lack of knowledge regarding the functional significance of these events. Does a 
given event occur in a functionally important region of the gene and alter its function? Until 
more is known about individual events, genome-wide studies of all detected instances of 
editing or alternative splicing in various treatment paradigms does little more than generate 
data. 
RNA Editing 
Adenosine to inosine (A-to-I) RNA editing is a post-transcriptional modification 
catalyzed by a family of widely expressed double-stranded RNA-specific adenosine 
deaminases acting on RNA (ADARs)9,379-381. In mammals, RNA editing alters the protein 
sequence (recoding) at a small proportion of all identified editing sites because the majority of 
A-to-I events reside in intronic, untranslated, or intergenic regions382-386. Comprehensive 
analysis of mRNA editing in our existing datasets was complicated by the uneven coverage of 
aligning reads and the number of genes in which more than one editing event occurs over a 
short distance. Realignment of sequence reads to allow more than two A/G mismatches could 
potentially enhance the existing analyses, however deeper sequencing and PCR validation will 
be required for more complete analysis. 
Editing events within the coding regions of a number of neurotransmitter receptors 
known to respond to cocaine cause changes to their RNA processing, channel subunit 
maturation/assembly, kinetics, gating properties, and trafficking, altering synaptic 
transmission387. We identified 15 A-to-I potential editing events occurring in five sequence 
libraries (NAc Saline, Cocaine, Withdrawal and PSD Saline and Cocaine) and 14 additional 
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events occurring in four of the five libraries (Table 6.1). Editing would lead to a change in 
protein coding in 12 of the 29 identified sites. The remaining identified sites fell in introns, 5’ or 
3’ UTRs, or were from noncoding RNAs. 
 We detected many of the functionally significant editing events known to occur in the 
coding regions of the glutamate, serotonin, GABA, and kainate neurotransmitter receptors 
(Fig. 6.1). Three editing sites were identified in the ionotropic glutamate receptor, Gria2 
(alpha-amino-3-hydroxy-5-methyl-4-isoxazol glutamate receptor, AMPA; also known as GluR2). 
Editing of the Q/R site alters channel calcium permeability and nearly complete Q/R editing is 
required for viability379,389. While the Q/R site was nearly 100% edited in all samples, partial 
editing occurred at the R/G site (Fig. 6.1A); receptors edited at the R/G site exhibit faster 
recovery from desensitization379. Under baseline conditions, PSD-localized Gria2 transcripts 
show less R/G editing than total tissue Gria2 transcripts. Gria2 R/G editing frequency at the 
PSD increased following cocaine exposure, while total tissue Gria2 R/G editing was unaltered 
(Fig. 6.1A). 
 Editing was detected at four sites in the serotonin receptor 5-HT2C (Htr2c), one site in 
Gabra3 (gamma-aminobutyric acid type A3 receptor), and at several sites in the kainate 
receptors Grik1 and Grik2 (Fig. 6.1B,C and Table 6.1). The serotonin receptor, 5-HT2C (Htr2c), is 
an extreme example of a gene in which more than one editing event occurs over a short 
distance; it has 5 A-to-I editing events in the span of 13 nucleotides, and it is known that 
multiple editing events often occur in a single transcript379,388. Similarly, we observed a K/E 
recoding editing event of unknown functional significance in Cyfip2 (cytoplasmic FMR1 
interacting protein 2), with lower baseline PSD editing that increased after cocaine (Fig. 6.1D). 
The editing profile for E/G recoding in a region of the calcium-dependent secretion activator 1 
(CADPS) protein crucial for its interaction with secretory vesicles391 was below 40% in all tissue  
  
 
Table 6.1  Table of A-to-I RNA editing events 
Identied potential RNA editing events in RNA-Seq libraries from NAc tissue lysates (Saline, Cocaine, Withdrawal) and striatal PSDs (Saline, Cocaine) . Table 
details the gene symbol, genomic coordinate, editing site information including recoding event, raw read depth with PHRED-score quality adjusted 
coverage for reads ≥ 30, and the percent alternate base ± 95% condence interval (CI). Site D of Htr2c was detailed by Burns et al. (1997)388. 
 
   NAc Sal NAc Coc NAc Wit PSD Sal PSD Coc 
Gene(s) Coordinate Site 
Read depth 
(Qual. adj. 
cov.) 
Percent Alt 
base (% edit 
± CI) 
Read depth 
(Qual. adj. 
cov.) 
Percent Alt 
base (% edit 
± CI) 
Read depth 
(Qual. adj. 
cov.) 
Percent Alt 
base (% edit 
± CI) 
Read depth 
(Qual. adj. 
cov.) 
Percent Alt 
base (% edit 
± CI) 
Read depth 
(Qual. adj. 
cov.) 
Percent Alt 
base (% edit 
± CI) 
4930578G10Rik chr4:42804740 Intron 6 (4) 100.0 ± 0.0 7 (6) 100.0 ± 0.0 2 (0) 100.0 ± 0.0 3 (3) 100.0 ± 0.0 14 (13) 100.0 ± 0.0 
4930578G10Rik chr4:42806801 W/R 7 (6) 71.4 ± 17.1 11 (9) 36.4 ± 14.5 11 (6) 63.6 ± 14.5 19 (17) 31.6 ± 10.7 41 (41) 53.7 ± 7.8 
Atp2b1 chr10:98378004 5’-UTR 4 (3) 50.0 ± 25.0 5 (4) 60.0 ± 21.9 6 (6) 33.3 ± 19.2 0 (0)  4 (4) 100.0 ± 0.0 
Blcap chr2:157383876 Q/R 48 (23) 31.3 ± 6.7 52 (32) 26.9 ± 6.2 59 (32) 25.4 ± 5.7 16 (6) 37.5 ± 12.1 0 (0)  
C330019G07Rik/ 
Pisd chr5:33081060 I/V 60 (45) 65.0 ± 6.2 53 (38) 69.8 ± 6.3 21 (18) 52.4 ± 10.9 76 (73) 35.5 ± 5.5 128 (125) 57.0 ± 4.4 
Cadps chr14:13244096 E/G 34 (22) 35.3 ± 8.2 41 (34) 31.7 ± 7.3 28 (19) 39.3 ± 9.2 76 (71) 26.3 ± 5.1 10 (10) 80.0 ± 12.6 
Cyp2 chr11:46086145 K/E 39 (10) 79.5 ± 6.5 102 (29) 83.3 ± 3.7 80 (34) 77.5 ± 4.7 34 (26) 29.4 ± 7.8 15 (15) 66.7 ± 12.2 
Dagla chr19:10320186 3’-UTR 30 (10) 53.3 ± 9.1 14 (4) 78.6 ± 11.0 14 (3) 78.6 ± 11.0 96 (33) 43.8 ± 5.1 156 (56) 44.2 ± 4.0 
Dlgap2 chr8:14306982 Intron 17 (0) 70.6 ± 11.1 18 (9) 61.1 ± 11.5 19 (3) 94.7 ± 5.1 51 (8) 90.2 ± 4.2 123 (34) 60.2 ± 4.4 
Gm14391/Gm14399/ 
Gm2026 
chr2:175024814 Intron 11 (7) 100.0 ± 0.0 15 (10) 100.0 ± 0.0 5 (3) 100.0 ± 0.0 7 (7) 100.0 ± 0.0 0 (0)  
Gon4l chr3:88689333 Intron 3 (1) 100.0 ± 0.0 6 (4) 83.3 ± 15.2 3 (3) 66.7 ± 27.2 0 (0)  8 (8) 100.0 ± 0.0 
Gpr137b chr13:13457408 T/A 16 (12) 37.5 ± 12.1 15 (10) 66.7 ± 12.2 8 (5) 37.5 ± 17.1 22 (21) 81.8 ± 8.2 68 (57) 35.3 ± 5.8 
Gria2 chr3:80496208 R/G 125 (91) 63.2 ± 4.3 106 (89) 51.9 ± 4.9 75 (59) 62.7 ± 5.6 37 (34) 32.4 ± 7.7 31 (30) 64.5 ± 8.6 
Gria2 chr3:80510834 Q/R 104 (47) 99.0 ± 1.0 114 (51) 100.0 ± 0.0 82 (35) 100.0 ± 0.0 3 (3) 100.0 ± 0.0 37 (21) 100.0 ± 0.0 
Gria3 chrX:39007429 R/G 22 (16) 95.5 ± 4.4 28 (17) 92.9 ± 4.9 22 (21) 86.4 ± 7.3 0 (0)  20 (18) 100.0 ± 0.0 
Grik1 chr16:87940788 Q/R 7 (4) 71.4 ± 17.1 4 (1) 100.0 ± 0.0 3 (2) 100.0 ± 0.0 12 (12) 100.0 ± 0.0 0 (0)  
Htr2c chrX:143604241 I/V (D-site) 15 (8) 53.3 ± 12.9 12 (9) 66.7 ± 13.6 0 (0)  14 (14) 100.0 ± 0.0 8 (8) 100.0 ± 0.0 
Ipw chr7:66929246 ncRNA 282 (177) 86.5 ± 2.0 601 (373) 93.7 ± 1.0 467 (303) 90.8 ± 1.3 0 (0)  49 (37) 63.3 ± 6.9 
Ipw chr7:66931777 ncRNA 19 (16) 26.3 ± 10.1 24 (17) 33.3 ± 9.6 0 (0)  3 (2) 100.0 ± 0.0 9 (7) 100.0 ± 0.0 
Myo3a chr2:22443824 Intron 7237 (556) 99.9 ± 0.0 5124 (452) 99.9 ± 0.0 3466 (328) 99.9 ± 0.0 7888 (125) 99.3 ± 0.1 7953 (162) 99.0 ± 0.1 
Myo3a chr2:22444034 Intron 7353 (547) 99.9 ± 0.0 7299 (784) 100.0 ± 0.0 5066 (545) 99.9 ± 0.0 7949 (172) 98.3 ± 0.1 7940 (167) 98.0 ± 0.2 
Myo3a chr2:22445548 Intron 195 (3) 100.0 ± 0.0 107 (6) 100.0 ± 0.0 82 (4) 100.0 ± 0.0 1518 (8) 99.9 ± 0.1 1435 (16) 99.7 ± 0.1 
Myo3a chr2:22445583 Intron 1209 (909) 99.9 ± 0.1 735 (584) 100.0 ± 0.0 429 (330) 100.0 ± 0.0 7980 (7569) 99.9 ± 0.0 7999 (7707) 100.0 ± 0.0 
Myo3a chr2:22445901 Intron 802 (47) 100.0 ± 0.0 561 (27) 100.0 ± 0.0 357 (17) 100.0 ± 0.0 31 (3) 90.3 ± 5.3 17 (0) 35.3 ± 11.6 
Rpa1 chr11:75114517 3’-UTR 16 (12) 81.3 ± 9.8 11 (7) 72.7 ± 13.4 5 (3) 80.0 ± 17.9 135 (111) 97.8 ± 1.3 105 (88) 88.6 ± 3.1 
Taf1b chr12:25194319 N/D or E/G 7 (5) 57.1 ± 18.7 8 (6) 37.5 ± 17.1 4 (4) 75.0 ± 21.7 91 (85) 68.1 ± 4.9 121 (120) 100.0 ± 0.0 
Tmem63b chr17:45799898 Q/R 65 (37) 64.6 ± 5.9 65 (38) 67.7 ± 5.8 31 (22) 61.3 ± 8.7 0 (0)  61 (59) 62.3 ± 6.2 
Zfp352 chr4:89892206 3’-UTR 18 (1) 100.0 ± 0.0 8 (0) 100.0 ± 0.0 7 (1) 100.0 ± 0.0 112 (2) 100.0 ± 0.0 118 (6) 100.0 ± 0.0 
Zfp804b chr5:7276845 Intron 1145 (103) 99.8 ± 0.1 573 (47) 99.7 ± 0.2 439 (39) 100.0 ± 0.0 121 (6) 100.0 ± 0.0 190 (6) 100.0 ± 0.0 
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Figure 6.1  A-to-I RNA editing in select genes 
Mismatch identification and quality filtering was performed using SAMTools pileup and varFilter390. 
Potential A-to-I editing sites occurring in multiple sequencing libraries were identified. Frequency of A-
to-I edits at the indicated genomic coordinate is shown as percent editing for (A) Gria2, (B) Htr2c, (C) 
Gabra3, (D) Cyfip2, (E) Cadps, and (F) Gria3. Recoding is indicated by the single letter amino acid code 
before the genomic coordinate. Sites A, B, and D of Htr2c were previously described388. Abbreviations: S, 
Saline; C, Cocaine; W, Withdrawal. 
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samples and at the PSDs of saline-treated mice but increased to 80% at the PSD after cocaine 
(Fig. 6.1E). 
Editing of the ionotropic glutamate receptor, Gria3 (also known as GluR3) occurs in the 
ligand interaction domain and causes R/G recoding392. Editing at this site is low in embryonic 
rat brain and increases markedly as development progresses; 80-90% of Gria3 transcripts are 
edited in humans393. Editing at the R/G site enables rapid recovery from desensitization 
thereby permitting a sustained response to rapid stimuli. It is believed that editing at this site 
occurs prior to splicing and can alter splice efficiency387. Consistent with previously published 
reports, we observed a very high degree of editing (< 80%) at the R/G site in all samples 
irrespective of treatment paradigm (Fig. 6.1F). 
Of note, amongst the genes with editing sites whose usage was responsive to cocaine 
(4930578G10Rik, Cadps, Cyfip2, Gpr137b, Gria2, Taf1b), editing at the PSD and in tissue lysates 
changed in opposite directions or only differed in the PSD (Table 6.1). 
Alternative Splicing 
 Similarly, our analysis of alternative splicing of the described mRNAs was incomplete 
and merits revisiting. While options exist for alternate isoform analysis25,26,394, the annotation of 
the mouse genome is far from complete, meaning that the available gene annotations 
undergo frequent changes. As with editing, the databases of known alternative splicing 
events are quite imperfect, which can produce misleading analyses. 
Between 92 and 97% of multi-exon human genes are alternatively spliced7,395,396 and 
splicing levels are especially high in the brain, where it plays an important role in synaptic 
plasticity33,397 ,398-402. For example, inclusion or exclusion of the three alternatively spliced exons 
of the NR1 subunit of the NMDA receptor is activity-dependent and affects receptor assembly 
and exit from the endoplasmic reticulum, trafficking, phosphorylation, and pharmacological 
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properties400. Although approximately 10% of aligning reads from the NAc lysates and 20% 
from striatal PSD libraries map to annotated exon-exon junctions, deeper coverage is needed 
to evaluate splicing of transcripts like those encoding NR1. 
 Since Methyl CpG Binding Protein 2 (Mecp2) mRNA is known to affect behavioral 
responses to cocaine and is alternatively spliced125,374,377,403, we carried out a direct analysis of 
PSD junction reads mapping to it (Fig. 6.2). Inclusion of exons 1, 2 and 3 allows translation to 
start in exon 2, generating MECP2A; when exon 2 is excluded, translation starts in exon 1, 
generating MECP2B404,405. Preliminary analysis shows that in the Sal PSD library, more reads 
spanned the junction between exons 1 and 2 or 2 and 3 (26 reads support inclusion of exon 2) 
than the junction between exons 1 and 3 (3 reads support exclusion of exon 2). In contrast, in 
the Coc PSD library, no junction reads supported exon 2 inclusion (MECP2A) while 4 junction 
reads supported exon 2 exclusion (MECP2B) (Fig. 6.2). Our data suggest a switch from MECP2A 
to the more readily translated MECP2B transcript at the PSD following cocaine treatment.  
 MECP2, a transcriptional regulator, was known to localize to the PSD66,406 and transcript 
levels were high enough to allow a preliminary analysis of its splicing. The longer N-terminus 
of MECP2B is compositionally similar to extracellular signal-regulated kinase-1 and is 
hypothesized to play a role in coupling synaptic signaling to regulation of transcription404. 
Exclusion of exon 2 from PSD-localized transcripts following cocaine treatment may facilitate 
synapse-to-nucleus signaling by shifting expression towards MECP2B. Recent studies 
implicate MECP2 and other epigenetic modifications in the molecular response to chronic 
cocaine125,374,377,403. These preliminary observations should be followed up with further studies.  
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Figure 6.2  Alternative splicing of Mecp2 
The exon/intron structure of the Mecp2 gene is shown; exclusion of exon 2 generates MECP2B 
(NM_001081979, variant 1) while inclusion of exon 2 generates MECP2A (NM_010788, variant 2). Reads 
observed in the striatal PSD Sal and Coc libraries are shown. 
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Conceptual and integrative approaches 
 Knockout and transgenic mouse models have provided invaluable insights for 
investigations into the behavioral, biochemical, and molecular effects mediated by single 
genes. The changes that occur as a result of drug abuse are widespread and occur at multiple 
levels of gene expression: epigenetic, transcriptional, post-transcriptional, translational, and 
post-translational. These changes most likely involve multiple brain regions and cell-types and 
act in a system-wide manner. At the present time we lack the data and analytic tools necessary 
to integrate all of these drug-induced changes into a single cohesive model. Global studies 
such as those outlined in the previous chapters emphasize the broad effects of drug exposure 
on neuronal gene expression. They emphasize the need for an integrative approach that 
combines mRNA, miRNA, and protein expression profiling with focused studies and innovative 
behavioral paradigms in pursuit of the factors that underlie addiction and develop integrated 
therapeutic approaches. 
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